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ABSTRACT 
The Antidotal Effect of Datura stramonium on the Toxicity 
of Carbofuran and Malathion Insecticides in  Rats   
By: Zuhour Yahia Shams Eldin Elshafei 
 
The purpose of the present study was to determine the antidotal effect of Datura 
stramonium (aqueous seed extract) (DSE) in the treatment of toxicity of two 
types of pesticides: carbofuran and malathion.  
 In the first experiment, (DSE) was used as a pretreatment to carbofuran toxicity 
compared to a reference drug (Atropine sulphate).It was studied  into twenty-
five albino rats arranged into five groups. The first Group dosed carbofuran 10 
mg/kg. The second, third and fourth groups received 5, 7.5mg /kg of (DSE) and 
Atropine sulphate of 17mg/kg respectively. After the administration of (DSE) 
and the drug, in the second, third and fourth groups they received carbofuran 10 
mg/kg body weight. The fifth group was a control.  
The second experiment was to determine the antidotal effect of (DSE) in 
treatment of malathion toxicity. It was studied into twenty-five albino rats 
arranged into five groups. Four groups (group one, two, three and four) received 
500mg/kg body weight of Malthion. After the administration of malathion in 
the four groups they received 5, 7.5mg /kg of (DSE) and 17mg/kg of Atropine 
sulphate respectively. The fifth group was a control.  
In the two experiments, blood sample was collected for assay of serum enzymes 
and metabolic indicators. The rats were sacrificed after twenty-four hours. 
Tissue specimens were processed for histopathology. 
The result of histopathology and biochemical in both experiments showed 
normal internal organs and normal levels of enzymes in the groups dosed 7.5 
mg/kg of (DSE) and the drug. The groups received 5mg /kg of (DSE) showed 
mild toxicity in the internal organ and slightly high levels of serum enzymes. 
The groups dosed the two insecticides only showed typical toxicity in the 
internal organs and high level of serum enzymes. This reveals that the (DSE) 
XII 
 
of 7.5 mg/kg has almost the same effect of the drug in treatment of both 
toxicities and indicates that the protective action of (DSE) against the two 
insecticides tested was dose dependant.  
The third experiment was designed to estimate the safety of higher doses of 
(DSE). It was studied into sixteen white rats arranged into four groups. Three 
groups received 7.5, 15 and 30 mg/kg of (DSE) respectively. The fourth was a 
control. The rats were sacrificed after twenty four hours. Blood sample was 
collected for analysis of serum enzymes and metabolic indicators. Tissues were 
processed for histopathology.  The rats dosed 15and 30 mg/kg of (DSE) showed 
typical toxicity in the internal organs with elevated level of serum enzymes. 
Rats received 7.5 mg/kg of (DSE) showed normal internal organs and normal 
levels of serum enzymes. These suggest that increasing the dose of (DSE) above 
the 7.5mg/ kg could be toxic to animals and indicate the safety of (DSE) 7.5 mg 
/kg dose in treatment of insecticides toxicity.  
 
 
  ﺑﺴﻢ ﺍﷲ ﺍﻟﺮﺣﻤﻦ ﺍﻟﺮﺣﻴﻢ
  (ﻭﻗﻞ ﺭﺑﻲ ﺯﺩﻧﻲ ﻋﻠﻤﺎﹰ:)ﻗﺎﻝ ﺗﻌﺎﻟﻰ                                                                           
  ﻤﻠﺨﺹ ﺍُﻷﻁﺭﻭﺤﺔ
  ﺍﻟﻜﺎﺭﺒﻭﻓﻴﻭﺭﺍﻥ ﺩﺍﺘﻭﺭﺍ ﺴﺘﺭﺍﻤﻭﻨﻴﻡ ﻋﻠﻰ ﺴﻤﻴﺔ ﻠﻟ ﺍﻟﺘﺭﻴﺎﻗﻲ ﺍﻷﺜﺭ
  ﻓﻲ ﺍﻟﻔﺌﺭﺍﻥ ﻭﺍﻟﻤﻼﺜﻴﻭﻥ 
  ﻓﻌﻲﺯﻫﻭﺭ ﻴﺤﻲ ﺸﻤﺱ ﺍﻟﺩﻴﻥ ﺍﻟﺸﺎ :ﺍﻋﺩﺍﺩ 
 
ﻓﻲ ﻤﻌﺎﻟﺠـﺔ ﺍﻟﺘﺴـﻤﻡ ( ﺍﻟﺴﻴﻜﺭﺍﻥ)ُﺼﻤﻤﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻟﺘﺤﺩﻴﺩ ﺍﻷﺜﺭ ﺍﻟﺘﺭﻴﺎﻗﻲ ﻟﻤﺴﺘﺨﻠﺹ ﻨﺒﺎﺕ ﺍﻟﺩﺍﺘﻭﺭﺍ 
  .ﻟﻨﻭﻋﻴﻥ ﻤﻥ ﺍﻟﻤﺒﻴﺩﺍﺕ ﻫﻤﺎ ﻜﺎﺭﺒﻭﻓﻴﻭﺭﺍﻥ ﻭﺍﻟﻤﻼﺜﻴﻭﻥ 
ﺠﺭﻉ  ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻤﺎﺌﻲ ﻓﻲ ﺍﻟﺘﺠﺭﺒﺔ ﺍﻷﻭﻟﻰ ﻗﺒل ﺇﺤﺩﺍﺙ ﺴﻤﻴﺔ ﺒﺎﻟﻜـﺎﺭﺒﻭﻓﻴﻭﺭﺍﻥ ﻭﺍﺴـﺘﻌﻤﻠﺕ ﺴـﻠﻔﺎﺕ ﹸ
ﺨﻤﺴﺔ ﻭﻋﺸﺭﻴﻥ ﻓﺄﺭﺍﹰ ﺃﺒﻴﻀـﺎ ﻭﺯﻋـﺕ ﻋﻠـﻲ ﺨﻤـﺱ  ﻋﻠﻰ ﺍﻟﺘﺠﺭﺒﺔ  ﺍﺠﺭﻴﺕ.ﺍﻷﺘﺭﻭﺒﻴﻥ ﻜﺩﻭﺍﺀ ﻤﺭﺠﻌﻲ
ﺤﻘﻨﺕ ﺍﻟﻤﺠﻤﻭﻋﺎﺕ ﺍﻟﺜﺎﻨﻴﺔ ﻭﺍﻟﺜﺎﻟﺜـﺔ . ﺠﺭﻋﺕ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻷﻭﻟﻰ ﻓﻤﻭﻴﺎﹰ ﺒﺎﻟﻜﺎﺭﺒﻭ ﻓﻴﻭﺭﺍﻥ ﻓﻘﻁ. ﻤﺠﻤﻭﻋﺎﺕ
ﺴﻠﻔﺎﺕ ﺍﻷﺘﺭﻭﺒﻴﻥ ﻤﻥ  ﻜﺠﻡ/ﻤﻠﻎ 71ﻜﺠﻡ ﻤﻥ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻨﺒﺎﺘﻲ ﻭ ﺒﺠﺭﻋﺔ/ﻤﻠﻎ5.7ﻭ 5ﻭﺍﻟﺭﺍﺒﻌﺔ ﺒﺠﺭﻋﺘﻴﻥ
  .ﺍﺴﺘﺨﺩﻤﺕ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺨﺎﻤﺴﺔ ﻜﺸﺎﻫﺩ.ﻟﻜﺎﺭﺒﻭﻓﻴﻭﺭﺍﻥﺠﺭﻋﺕ ﺒﻌﺩﻫﺎ ﺒﺎﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻲ ﺜﻡ 
ﻋﻠـﻰ  ﺃﺠﺭﻴﺕ ﺍﻟﺘﺠﺭﺒـﺔ . ﺼﻤﻤﺕ ﺍﻟﺘﺠﺭﺒﺔﺍﻟﺜﺎﻨﻴﺔ ﻟﺘﻘﻴﻴﻡ ﺍﺴﺘﻌﻤﺎل ﻨﻔﺱ ﺍﻟﻤﺴﺘﺨﻠﺹ ﻟﻌﻼﺝ ﺴﻤﻴﺔ ﺍﻟﻤﺎﻟﺜﻴﻭﻥﹸ
, ﺍﻷﻭﻟـﻰ ) ﺠﺭﻋـﺕ ﺃﺭﺒـﻊ ﻤﺠﻤﻭﻋـﺎﺕ ﹸ.ﺨﻤﺴﺔ ﻭﻋﺸﺭﻴﻥ ﻓﺄﺭﺃﺒﻴﺽ ﻭﺯﻋﺕ ﻋﻠﻰ ﺨﻤـﺱ ﻤﺠﻤﻭﻋـﺎﺕ 
ﺍﻟﺜﺎﻟﺜﺔ ﻭﺍﻟﺭﺍﺒﻌـﺔ ﺒﻌـﺩ ,ﻨﺕ ﺍﻟﻤﺠﻤﻭﻋﺎﺕ ﺍﻟﺜﺎﻨﻴﺔ ﺤﻘ. ﻜﻐﻡ ﻤﻼﺜﻴﻭﻥ/ﻤﻠﻎ005ﺒﺠﺭﻋﺔ( ﺍﻟﺜﺎﻟﺜﺔ ﻭﺍﻟﺭﺍﺒﻌﺔ,ﺍﻟﺜﺎﻨﻴﺔ
. ﻜﺠـﻡ ﻤـﻥ ﺴـﻠﻔﺎﺕ ﺍﻷﺘـﺭﻭﺒﻴﻥ /ﻤﻠﻎ71ﻜﺠﻡ ﻭ/ﻤﻠﻎ5.7ﻤﻠﻎ ﻭ5ﺘﺠﺭﻴﻊ ﺍﻟﻤﺒﻴﺩ ﺒﺠﺭﻋﺘﻴﻥ ﻤﻥ ﺍﻟﻤﺴﺘﺨﻠﺹ
 . ﺍﺴﺘﺨﺩﻤﺕ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺨﺎﻤﺴﺔ ﻜﺸﺎﻫﺩ
ﺃﺨﺫﺕ ﻋﻴﻨﺎﺕ ﻤﻥ ﺍﻟﺩﻡ ﻟﻜﺸـﻑ ﺘﺭﻜﻴﺯﺍﻷﻨﺯﻴﻤـﺎﺕ ﺍﻟﻤﺼـﻠﻴﺔ . ﺃﻋﺩﻤﺕ ﺍﻟﻔﺌﺭﺍﻥ ﺒﻌﺩ ﺃﺭﺒﻊ ﻭﻋﺸﺭﻴﻥ ﺴﺎﻋﺔﹸ
ﻭﺍﻟﻤﺅﺸﺭﺍﺕ ﺍﻷﻴﻀﻴﺔ ﻭﺠﻤﻌﺕ ﻋﻴﻨﺎﺕ ﺃﻨﺴﺠﺔ ﻟﻠﻔﺤﺹ ﺍﻟﻨﺴﻴﺠﻲ ﺍﻟﺩﻗﻴﻕ ﺍﻟﺫﻯ  ﺃﻭﻀﺢ ﺃﻥ ﺍﻷﻋﻀﺎﺀ ﺍﻟﺩﺍﺨﻠﻴﺔ 
ﻟﻙ ﻜﺠﻡ ﻭﺴﻠﻔﺎﺕ ﺍﻷﺘﺭﻭﺒﻴﻥ ﻁﺒﻴﻌﻴﺔ ﻓﻲ ﺍﻟﺘﺠﺭﺒﺘﻴﻥ ﻭﻜـﺫ /ﻤﻠﻎ5.7ﻟﻠﻤﺠﻤﻭﻋﺎﺕ ﺍﻟﻤﻌﺎﻟﺠﺔ ﺒﺎﻟﻤﺴﺘﺨﻠﺹ ﺒﺠﺭﻋﺔ
 ﻜﺠﻡ ﺍﺭﺘﻔﺎﻉ ﻁﻔﺒﻑ ﻓﻲ /ﻤﻠﻎ 5ﺃﻅﻬﺭﺕ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺘﻲ ﻋﻭﻟﺠﺕ ﺒﺎﻟﻤﺴﺘﺨﻠﺹ ﺒﺠﺭﻋﺔ .ﻤﺴﺘﻭﻱ ﺍﻹﻨﺯﻴﻤﺎﺕ
 ﺃﻭﻀﺤﺕ ﺍﻟﻤﺠﻤﻭﻋﺎﺕ ﺍﻟﺘﻲ ﺠﺭﻋـﺕ ﺒﺎﻟﻤﺒﻴـﺩﻴﻥ . ﻤﺴﺘﻭﻯ ﺍﻹﻨﺯﻴﻤﺎﺕ ﻭﻭﺠﻭﺩ ﺴﻤﻴﺔ  ﻓﻲ ﺍﻷﻋﻀﺎﺀ ﺍﻟﺩﺍﺨﻠﻴﺔ
ﻩ ﺍﻟﻨﺘـﺎﺌﺞ ﻫﺫ. ﺘﻌﺎﻟﺞ ﺍﺭﺘﻔﺎﻋﺎ ًﻓﻲ ﻤﺴﺘﻭﻯ ﺍﻹﻨﺯﻴﻤﺎﺕ ﺍﻟﻤﺼﻠﻴﺔ ﻤﻊ ﺴﻤﻴﺔ ﻭﺍﻀﺤﺔ ﻓﻲ ﺍﻷﻋﻀﺎﺀ ﺍﻟﺩﺍﺨﻠﻴﺔﹸﻭﻟﻡ 
ﻜﺠﻡ ﻟﻪ ﺘﻘﺭﻴﺒﺎ ﻨﻔﺱ ﺃﺜﺭﺴـﻠﻔﺎﺕ ﺍﻷﺘـﺭﻭﺒﻴﻥ ﻟﻌـﻼﺝ ﺴـﻤﻴﺔ /ﻤﻠﻎ5.7ﺘﺜﺒﺕ ﺃﻥ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻨﺒﺎﺘﻲ ﺒﺎﻟﺠﺭﻋﺔ
  .ﺒﺎﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻨﺒﺎﺘﻲ ﻴﻌﺘﻤﺩ ﻋﻠﻰ ﺍﻟﺠﺭﻋﺔ  ﺍﻟﻤﺒﻴﺩﻴﻥ ﺴﻤﻴﺔ ﻜﻤﺎ ﻴﺅﻜﺫ ﺃﻥ ﻋﻼﺝ. ﺍﻟﻤﺒﻴﺩﻴﻥ
ﺴﺘﺔ ﻋﺸﺭ ﺩﺭﺴﺕ ﻫﺫﻩ ﺍﻟﺘﺠﺭﺒﺔ  ﻓﻲ . ُﺼﻤﻤﺕ ﺍﻟﺘﺠﺭﺒﺔﺍﻟﺜﺎﻟﺜﺔ ﻟﺘﺤﺩﻴﺩ ﻤﺄﻤﻭﻨﻴﺔ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺒﺠﺭﻋﺎﺕ ﺃﻋﻠﻰﹸ
ﺤﻘﻨﺕ  ﺜﻼﺙ ﻤﺠﻤﻭﻋﺎﺕ ﺒﺜﻼﺙ ﺠﺭﻋﺎﺕ ﻤـﻥ ﺍﻟﻤﺴـﺘﺨﻠﺹ ﹸ. ﻓﺄﺭﺍﹰ ﺃﺒﻴﻀﺎﹰ ﻭﺯﻋﺕ ﻋﻠﻰ ﺃﺭﺒﻊ ﻤﺠﻤﻭﻋﺎﺕ
ﺫﺒﺤﺕ ﺍﻟﻔﺌﺭﺍﻥ ﺒﻌﺩ ﺍﺭﺒﻊ ﻭﻋﺸﺭﻴﻥ ﺴﺎﻋﺔ ̉. ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﺭﺍﺒﻌﺔ ﺍﺴﺘﺨﺩﻤﺕ ﻜﺸﺎﻫﺩ. ﻜﺠﻡ/ﻤﻠﺠﻡ 03ﻭ51،5.7
ﺴـﻤﻴﺔ ﺃﺨﺫﺕ ﻋﻴﻨﺎﺕ ﺃﻨﺴﺠﺔ ﻟﻠﻔﺤﺹ ﺍﻟﻨﺴﻴﺠﻲ ﺍﻟﺩﻗﻴﻕ  ﺍﻟﺫﻱ ﺃﺜﺒﺕ ﻭﺠﻭﺩ . ﺤﻠل ﺍﻟﻤﺼل ﻟﻘﻴﺎﺱ ﺍﻻﻨﺯﻴﻤﺎﺕ
وارﺗﻔѧﺎع ﻓѧﻲ ﻣﺴѧﺘﻮى  (ﻜﺠـﻡ /ﻤﻠﺠـﻡ  03ﻭ51)ﻭﺍﻀﺤﺔ ﻓﻲ ﺍﻷﻋﻀـﺎﺀ ﺍﻟﺩﺍﺨﻠﻴـﺔ  ﻓـﻲ ﺍﻟﻤﺠﻤـﻭﻋﺘﻴﻥ  
آﺎﻧѧﺖ ﻜﺠـﻡ /ﻤﻠﺠـﻡ  5.7 اﻟﻤﺠﻤﻮﻋѧﺔ اﻟﺘѧﻲ ﺣﻘﻨѧﺖ ﺑﺠﺮﻋѧﺔ .  ﻓﻲ اﻟﺸѧﺪة  ﻤﻊ ﺘﻔﺎﻭﺕ ﺘﺭﻜﻴﺯﺍﻷﻨﺯﻴﻤﺎﺕ ﺍﻟﻤﺼﻠﻴﺔ
ﺘﻌﻤﺎل ﺁﻤﻨﺔ ﻟﻼﺴ ﻜﺠﻡ/ﻤﻠﺠﻡ 7. 5هﺬا ﻳﺆآѧﺪ أن اﻟﺠﺮﻋѧﺔ . أﻋﻀﺎءهﺎ اﻟﺪاﺧﻠﻴﺔ ﻃﺒﻴﻌﻴﺔ  وآﺬﻟﻚ ﺗﺮآﻴﺰ اﻻﻧﺰﻳﻤﺎت
  .ﻓﻲ ﺍﻟﺤﻴﻭﺍﻥ ﻭﺃﻱ ﺠﺭﻋﺔ ﺃﻋﻠﻰ ﻤﻨﻬﺎ ﻗﺩ ﺘﺸﻜل ﺨﻁﺭﺍﹰ ﻋﻠﻴﻪ
 
 INTRODUCTION 
 
Plants have always played a major role in the treatment of animals' traumas 
and diseases worldwide. They have been used as sources of modern drugs, 
either by providing pure compounds, starting materials for partial synthesis of 
useful compounds or models for synthesis of new drugs. 
The reasons for the frequent use of traditional medicine being: the strong 
association of people with local flora and their belief on traditional knowledge 
regarding plants as medicine, easy availability of local medicinal plants, 
relatively poor access to synthetic drugs and their high cost, plus lower 
economic profile of the people. 
According to the World Health Organization (WHO 1978a), 80% of the world 
population uses medicinal plants in the treatment of diseases and in African 
countries, this rate are much higher. WHO has developed the first global 
WHO Traditional Medicine Strategy in 2002 (WHO 2002-2005). For their 
importance Sudan has developed a system to regulate and register these 
medicinal plants through National Medicines and Poisons Board. 
 
In all countries of the world, there exists traditional knowledge related to the 
health of humans and animals. According to the World Health Organization 
(WHO 1978a), the definition of traditional medicine may be summarized as 
the sum total of all the knowledge and practice, whether explicable or not, 
used in the diagnosis, prevention and elimination of physical, mental or social 
imbalance and relying exclusively on practical experience and observation 
handed down from generation to generation, whether verbally or in writing. 
Traditional medicine might also be considered as a solid amalgamation of 
dynamic medical known-how and ancestral experience. In Africa, traditional 
healers and remedies made from plants play an important role in the health of 
 millions of people. In Sudan, traditional medicine is closely related to religion 
an d other powerful beliefs 
There are many traditional healers throughout the country but they are mainly 
found in the central states, especially in the Gezira area, (Ahmed et al 1999). 
The relative ratios of traditional practitioners and university trained doctors in 
relation to the whole population in African countries are revealing. In Ghana, 
for example, for every traditional practitioner there are 200 people, against 
one university trained doctor for nearly 20,000 people. The same applies to 
Swaziland where the ratios are for every traditional healer there are 100 
people while for every university trained doctor there are 10,000 people 
(WHO, 1984), The WHO has called for recognition of traditional healers, and 
in 1978 declared at Alma Ata that African traditional healers should be part of 
the primary health care team (WHO, 1978a).  
Folk medicines including herbal medicines and teas, in which the active 
compounds of the plants are directly used, are the most commonly used of 
medicinal plants. The use of pure active compounds, obtained from medicinal 
plants, is also widely used. The Sudanese have inherited a rich knowledge on 
medicinal plants and a wide some of Sudanese Medicinal Culinary and 
Aromatic Plants are used in folk medicines. cassia senna (known locally as 
sannamaka) grows in North, West and middle of Sudan. The fruits are used as 
purgatives. Solenostemma argel (known locally as Hargel) grows in Northern 
Sudan and is used as antispasmodic.Haplophylum tuberculat (known as Haza) 
grows in Northern Sudan and is used as antidiarrheal. Sudanese women also 
traditionally utilize fragrances in the fumigant sauna. These mainly consist of 
either Acacia seyal (known as Shaf) or Terminalia brownii (known as Talih) 
this sauna is also used for medicinal purposes (e.g. rheumatism). There are 
many other plants which are used as food, flavoring, perfumes and other 
medicinal purposes (Mofida, 2003). 
 The overall effect of any herbal scientific study is to establish or confirm the 
credibility of the use of that herb or medicinal plants as an effective source of 
both traditional and modern medicine, and that what has been attempted to 
investigate in this study 
The objectives of this study were:  
-To investigate the use of D.stramonium seed extract in treatment of 
insecticide toxicity. 
-To determine the safety use of D.stramonium seed extract as an antidote to 
poisoning in correlation with doses and the possibility of increasing the 
chosen dose. 
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CHAPTER ONE 
LITERATURE REVIEW 
Sudan has a very unique geographical position. This is reflected in its diverse 
climate and its varied natural resources. This makes suitable for cultivation 
and growth of many plants. Thus, the flora of the Sudan consists of 3137 
species of flowering plants belonging to 170 family and 1280 genera. Of 
these, 278 species and 210 genera and 72 families have already been 
identified and Sudanese Medicinal Culinary and Aromatic Plants Research is 
expected to identify others (Elamin, 1990; Elghazali, 1986; Elghazali, et al, 
1987; 1994; 1997). 
 
The increasing interest in medicinal plants promoted the scientist all over the 
world to investigate their biological use since these medicinal plants are 
essential for treatment of many important diseases where other cures have yet 
to be found. 
1.1. Plant used in this experiment: Datura stramonium 
1.1.1Taxonomy:  
Kingdom Plantae- plants 
Subkingdom Tracheobionta--  vascular plants 
Division Magnoliophyta - flowering plants, angiosperms 
Class  Magnoliopsida- dicots, dicotyledons 
Subclass Asteridae 
Order Solanales 
Family Solanaceae—nightshades 
Genus Datura  
Spesies Datura stramonium    
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1.1.2. Common Names:  
Jimson Weed is a common name of Datura stramonium which belongs to the 
family Solanaceae. The plant is native to Asia, but is also found in the West 
Indies, Canada, and the United States. Of the more than 12 species, Datura 
stramonium is the most common type found in the eastern United States.( 
Ellenhorn, 1988) Many names have been given to this plant including: Jimson 
Weed, Locoweed, Angel's Trumpet, Thorn Apple, Devil's Trumpet, Mad 
Apple, Stink Weed, Sacred Datura, Green Dragon, and Devil's Trumpet. 
(Ellenhorn, 1988, Goldfrank, 1994). In Sudan it is locally named( Alsikran) 
1.1.3 Habitat: 
 Datura stramonium grows in dry waste ground and amongst rubble or the 
ruins of old buildings (Livingstone, 1978, Chiej, 1984 Hadad and Winchester 
1990). It grows common weed along roadsides, in cornfields and pastures, 
and in waste areas ( Ellenhorn, 1988). The plant prefers light (sandy) and 
medium (loamy) soils and requires well-drained soil. The plant prefers neutral 
and basic (alkaline) soils. It cannot grow in the shade. It requires dry or moist 
soil. 
In Sudan, D. stramonium is widely distributed at Kassala, Dongla, Barber, 
Nuba mountains and Khartoum Province (Khadiga 1995) 
1.1.4. Description of the plant: 
Datura stramonium(FIg1, 2 and 3)  is an annual plant. It grows 4 to 6 feet tall 
and has dark green, long stemmed, lobed leaves that exude a foul odor. Its 
flower that four lobed, thorny, green seed pod fruit ripens in early falls. Each 
lobe contains 50-100, 2-3 mm, kidney-shaped, black blooms in late spring is 
usually white, sometimes lavender, solitary and tubular brown seeds. 
(Ellenhorn 1988, Goldfrank1994)
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Fig (1) Datura stramonium natural growth 
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Fig (2): Datura setramonium fruit  
A                                                            B 
                                      
                                  
D                                                                      c                  
                       
 A- D. stramonium ripe fruit 
 B -.D. stramonium green fruit             
C and D-   Four segmented lobes of D.stramonium containing ripe seeds.                            
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 Fig (3) Daura stramonium seeds                       
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It is in flower from July to October, and the seeds ripen from August to 
October. The flowers are hermaphrodite (have both male and female organs) 
and are pollinated by Moths. 
1.1.5. History and folklore: 
The origin of D. stramonium is disputed (Curtain, 1947). The Sanskrit 
dhattura and the Hindustani dhatur formed the basis of the general name, the 
origin of Jimson weed could be Asiatic. Some sources report a probable 
Central American origin, due to D.stramonium habitation of most temperate 
and subtropical parts of the world. "The native names applied by ethnic 
groups appear to be based upon the deliriant effects produced by the plant on 
the nervous system" (Bye et al 1991).Throughout the ages, the Devil's 
Trumpet has been used for both intoxication and as medicine. 
The plant has been described throughout history as a toxin famous for its 
mind-altering properties. There are references to it in Homer's Odyssey, and 
Shakespeare's plays: Hamlet, Romeo and Juliet, and Anthony and Cleopatra. 
(Ellenhorn, 1988). 
It is one of a group of plants known as "belladonnas," thought to be named 
from their use by Italian women to dilate their pupils, which was considered 
beautiful. (Gilman 1990) Its most common name, Jimson Weed, is a 
contracted form of Jamestown Weed, after its use was described in 1676, in 
Jamestown, Virginia. Jimsonweed is named for a case of human poisoning in 
Jamestown, Virginia, when British troops sent to halt Bacon's Rebellion; 
soldiers were poisoned by eating the plant in a salad and then suffered 
delirium and hallucinations. (Goldfrank ,1994). 
In some tribes D. stramonium was involved in the ceremonies of manhood. 
The sadhus(is a common term for a mystic, an ascetic, practitioner of yoga 
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(yogi) and/or wandering monks) of Hinduism also used D. stramonium as a 
spiritual tool, smoking it with cannabis in their traditional chillums. It was 
also widely used by the Magyar (Hungarian) spiritual leaders (the Táltos) 
since ancient times (Ratsch 2005) 
1.1.6 Active Compounds and pharmacology 
 
The toxic principles are tropane belladonna alkaloids which possess strong 
anticholinergic properties (Ruhwald, 2005). These alkaloids include, 
hyoscyamine (stems, leaves, roots, seeds), hyoscine (roots); atropine (d,l-
hyoscyamine) and scopolamine (l-hyoscine) (Miraldi, et al, 2001,. 
Steenkamp, et al,2004) All parts of the plant are toxic, but the greatest amount 
of alkaloids is contained in ripe seeds (Day and Dilworth 1984, Dugan et al 
1989 , Boumba, et al 2004, Ruhwald 2005). Young, dried leaves (Naude, et 
al, 2005) and stems and leaves of young plants (Miraldi, et al, 2001) 
They act as competitive antagonists to acetylcholine at peripheral and central 
muscarinic receptors at a common binding site. (Gilman, 1990) 
 The peripheral receptors are on exocrine glands which affect sweating, 
salivation, and smooth and cardiac muscle. Poisoning results in wide-spread 
paralysis of parasympathetic innervated organs. (Ellenhorn, 1988). 
As tertiary amines they also have central nervous system absorption, inhibit 
CNS receptors and result in a central anticholinergic syndrome of acute 
psychosis or delirium ((Haddad and Winchester, 1990). 
Tropane alkaloids are some of the few substances which cause true 
hallucinations . Scopolamine can be slowly and erratically absorbed into the 
brain. In most people, scopolamine reaches the brain within an hour or so 
after ingestion and causes visual and auditory hallucinations. Scopolamine 
acts as a competitive antagonist at muscarinic acetylcholine receptors, 
specifically M1 receptors; it is thus classified as an anticholinergic,anti-
muscarinic drug. The exact concentration of specific alkaloids varies with 
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species, cultivation, environment, temperature, moisture, and storage. The 
range of toxicity is highly variable and unpredictable; toxicity may vary from 
leaf to leaf, plant to plant and season to season. This contributes to the danger 
of misuse of the plant since the dose cannot be predicted. (Haddad and 
Winchester, 1990). The highest concentration of alkaloids occurs in the seeds 
approximately 0.1 mg of atropine per seed or 3-6 mg/50-100 seeds. 
(Goldfrank, 1994). Toxicity of D. stramonium is induced when they are 
ingested, smoked and absorbed topically especially through mucous 
membranes. 
 
These toxins are easily absorbed from mucous membranes and the 
gastrointestinal tract. The half-life of atropine is approximately 4 hours. 
Metabolism occurs in the liver by hydrolysis which eliminates approximately 
half the drug. The remainder is excreted unchanged in the urine. (Ellenhorn, 
1988, Gilman, 1990) 
It is estimated that 100 seeds contain 6 mg of atropine equivalent. (Frohne and 
Pfander, 1984, Palmer et al 2002) the authors estimated that 1 g of seeds 
contained 8.34 mg of atropine. Younger plants have less atropine and 
scopolamine content in the seed; these concentrations increase as the plant 
ages. ( Miraldi et al 2001). 
 
 
1.1.7. Clinical effects and toxicity: 
 
The thorn apple is a bitter narcotic plant that relieves pain and encourages 
healing (Bown, 1995). It has a long history of use as a herbal medicine, 
though it is very poisonous and should be used with extreme caution. 
The mnemonic for clinical effects of typical atropine poisoning is: "blind as a 
bat, mad as a hatter, red as a beet, hot as a hare, dry as a bone, the bowel and 
bladder lose their tone, and the heart runs alone." Symptoms include 
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mydriasis, cycloplegia, flushed, warm, dry skin; dry mouth; ileus, urinary 
retention, tachycardia, hyper or hypotension, delirium with hallucinations, 
jerky, myoclonic movements, choreoathetosis, hyperthermia, coma, 
respiratory arrest, rare seizures, and central stimulation followed by 
depression. (Haddad and Winchester, 1990) Hallucinations are reported in as 
many as 83% of cases, typically they are simple visual images in natural 
colors, but frequently also tactile hallucination of crawling insects (Ellenhorn, 
1988). The onset of symptoms occurs within 30 to 60 minutes after smoking 
leaves or drinking tea; and 1-4 hours after ingestion of plant material or seeds 
(Goldfrank, 1994) Initial symptoms include dry mouth then pupil dilatation. 
(Ellenhorn 1988). 
 The duration of symptoms is often 24-48 hours because of delayed 
gastrointestinal motility; symptoms have been reported to last up to 1-2 
weeks. Although, poisoning may lead to fatal medullary paralysis arrhythmias 
and Cardiovascular Collapse, (Hanna 1992).Jimson Weed-relat ed deaths 
mainly are as a result of impaired judgment and coordination resulting in risk-
taking activities associated with accidental death. (Ellenhorn, 1988, Coremans 
et al 1994) All Animals species can be poisoned. The literature mentions 
poisoning of cattle, goats, horses, poultry, sheep, and swine. Because of the 
plant's strong odor and unpleasant taste, animals consume it only when other 
food is not available. The seeds are sometimes milled with other seeds and 
have caused problems Jimsonweed can be harvested with hay or silage, and 
subsequently poisoning occurs upon feeding the forage. Seeds can 
contaminate grains and is the most common poisoning that occurs in 
chickens. (Cooper and Johnson, 1984, Cheeke and Schull 1985, Lampe and 
McCann, 1985).  
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1.1.8. Medicinal Uses: 
It has a long history of use as herbal medicine, though it is very poisonous and 
should be used with extreme caution. The leaves, flowering tops and seeds are 
anodyne, antiasthmatic, antispasmodic, hallucinogenic, hypnotic, mydriatic 
and narcotic (Chiej, 1984, Launert, 1981, Bown, 1995) 
D. stramonium is now used to treat asthma, and gastrointestinal problems, 
also aches, abscesses, arthritis, boils, headaches, hemorrhoids, rattlesnake 
bites, sprains, swellings, and tumors (Sandoval, 1998). It acts as a sedative in 
large doses and as a stimulant and deleriant in high doses. D. stramonium is 
an anodyne, antibiotic, antispasmodic and narcotic. Relieving the pains of 
rheumatism and sciatica when applied as an ointment, and easing spasms of 
Parkinsons disease are unproven accounts of the effects of Jimson weed. An 
ointment of the ground seeds and suet is rubbed on boils, pimples, and 
swellings; the powdered leaves are applied to hemorrhoids; and hot baths 
containing the plant give relief to colds and diarrhea (Curtain, 1947) 
Most of the plant is used for medicinal reasons. Eating the seeds rapidly gets 
the plant to the nervous system, but also increases the risk of lethal overdose. 
The leaves can be dried and smoked to relax the bronchiole muscles of the 
throat, and leaves are used also to line beds of those with insomnia. 
(Sandoval, 1998)   recommends using the fresh leaves, flowers, or seeds. In 
an infusion, 2 teaspoons of fresh leaves per cup of hot water, or a poultice 
using any variation of the recommended parts. 
The thornapple is a bitter narcotic plant that relieves pain and encourages 
healing (Bown, 1995). 
The leaves can be used as a very powerful mind-altering drug, they contain 
Hyoscyamine and Atropin, and there are also traces of scopolamine, a potent 
 14
cholinergic-blocking hallucinogen, which has been used to calm schizoid 
patients (Weiner, 1980).Atropine dilates the pupils and is used in eye surgery 
(Goldfrank ,1994). 
The leaves have been smoked as an antispasmodic in the treatment for 
asthma, though this practice is extremely dangerous (Weiner, 1980, Foster 
and Duke, 1990). Also as analgesic, anthelmintic and anti-inflammatory, they 
are used in the The leaves have been smoked as an antispasmodic in the 
treatment for asthma, though this practice is extremely dangerous (Weiner, 
1980, Foster and Duke, 1990). Also as analgesic, anthelmintic and anti-
inflammatory, they are used in the treatment of stomach and intestinal pain 
due to worm infestation, toothache and fever from inflammations (Tsarong, 
1994). Externally, it is used as a poultice or washes in the treatment of 
fistulas, abscesses wounds and severe neuralgia (Bown, 1995, Moerman, 
1998) seeds are used in Tibetan medicine, they are said to have a bitter and 
acrid taste with a cooling and very poisonous potency (Tsarong, 1994) It 
should be used with extreme caution and only under the supervision of a 
qualified practitioner since all parts of the plant are very poisonous and the 
difference between a medicinal dose and a toxic dose is very small (Lust, 
1983, Weiner, 1980, Bown, 1995). The antidote of choice for poisoning is 
physostigmine. The growing plant is said to protect neighboring plants from 
insects (Riotte, 1978) 
Treatment of patients following an organophosphate (OP) exposure can 
deplete a hospital's entire supply of atropine. Given the possibility of multiple 
severe exposures after a terrorist attack OP nerve agents; there exists a need 
for either greater atropine stores or the using development of alternative 
antidotes. Jimson weed (D. stramonium) contains atropine and other 
anticholinergic compounds and is common and readily available (Theodore et 
al, 2004) 
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Jimson weed extract was used as a protective agent in severe 
Organophosphate toxicity; by (Theodore, et al 2004). They have proved that 
pretreatment with Jimson weed extract significantly increases survival 
following severe dichlorvos exposure in white rats. 
1.2. Pesticides:  
The use of organophosphate and carbamate pesticides for pest control on or 
around animals has increased. In general, the organophosphate and carbamate 
pesticides are more toxic to warm-blooded animals there were increased 
incidences of pesticide poisonings among domestic and agricultural animals, 
it is necessary to recognize the signs of pesticide poisoning in animals and 
initiate prompt treatment when poisoning is suspected.  
1.2.1 Malathion:  
Malathion is a general use pesticide. It is available in emulsifiable 
concentrate, wettable powder, dustable powder, and ultra low volume liquid 
formulations 
Malathion is one of the most commonly usedOrganophosphates, it has a wide 
range of uses including agriculture, stored grain and forests. It is used to 
control a large variety of pests, including mosquitoes, grasshoppers, gypsy 
moths, Mediterranean fruit flies, mites, aphids, spider mites, and scales.( 
Brenner, 1992) It is applied via ground and aerial sprays, aerosols, foggers, 
baits, paints, pet collars, animal dips, animal dust bags, and cattle feed blocks. 
 
1.2.1.1. Mode of action 
 
Malathion works by attacking the nervous system; it is essentially a nerve 
poison. Specifically, it inhibits the action of an enzyme called 
acetylcholinesterase (AChE). (WHO, 1986, U.S. E.P.A, 2000). AChE works 
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to break down another chemical, acetylcholine, which is essential in 
transmitting impulses between nerves. Therefore, when malathion is used, 
AChE becomes unable to break down acetylcholine, which consequently 
accumulates in nerve cells. This abnormal acetylcholine build-up can cause in 
coordination, rapid twitching, in coordination, paralysis and death. (Tucker 
and Thompson, 1987, Gallo and Lawryk, 1991). 
Malathion’s toxicity is increased by its break-down products and 
contaminating chemicals. For instance, as malathion reacts and breaks down 
within an organism or in sunlight, one of the chemicals released is malaoxon. 
Malaxon is 40 times more toxic than malathion, and is the primary source of 
malathion’s toxicity. (Borwn et al, 1993).  In addition, there are 11 chemicals 
that are created in the malathion production process which can often be found 
in malathion. 
  1.2.1.2 Toxicity of Malathion:  
Malathion is slightly toxic via the oral route, with reported oral LD50 values 
of 1000 mg/kg to greater than 10, 000 mg/kg in the rat, and 400 mg/kg to 
greater than 4000 mg/kg in the mouse.  In another study, it is estimated that 
Ld 50 in rats is 390-480 mg/kg (Hazleton and Holland, 1953) 
 It is also slightly toxic via the dermal route, with reported dermal LD50 
values of greater than 4000 mg/kg in rats effects of malathion are similar to 
those observed with other organophosphates, except that larger doses are 
required to produce them. It has been reported that single doses of malathion 
may affect immune system response. (Gallo, and Lawryk, 1991) 
Symptoms of acute exposure to organophosphate or cholinesterase-inhibiting 
compounds may include the following: numbness, tingling sensations, 
incoardination, headache, dizziness, tremor, nausea, abdominal cramps, 
sweating, blurred vision, difficulty breathing or respiratory depression, and 
 17
slow heartbeat.Very high doses may result in unconsciousness, incontinence, 
and convulsions or fatality. The acute effects of malathion depend on product 
purity and the route of exposure other factors which may influence the 
observed toxicity of malathion include the amount of protein in the diet and 
gender. As protein intake decreased, malathion was increasingly toxic to the 
rats (Carlson, 1987) 
 Malathion has been shown to have different toxicities in male and female rats 
and humans due to metabolism, storage, and excretion differences between 
the sexes, with females being much more susceptible than males (Menzer, 
1987). 
Rats fed dietary doses of 5 mg/kg/day to 25 mg/kg/day over 2 years showed 
no symptoms apart from depressed cholinesterase activity. When small 
amounts of the compound were administered for 8 weeks, rats showed no 
adverse effects on whole-blood cholinesterase activity (Gallo, and Lawryk, 
1991). Weanling male rats were twice as susceptible to malathion as adults 
Malathion is mutagenic and carcinogenic (Cantor, et al. 1992.)Has been 
implicated in vision loss, kidney damage (Albright, et al. 1983) .It has been 
shown to cause DNA abnormalities (Balaji and Sasikala, 1993). A 2002 study 
by scientists from Assan and North-Eastern Hill Universities (India) showed 
that malathion given orally caused genetic damage in laboratory mice (Giri, et 
al. 2002). Another 2002 study, from Egypt's National Research Center, 
showed that mice fed with stored wheat that had been treated with a 
commercial malathion insecticide developed two kinds of genetic damage. 
The damage occurred at all dose levels tested in this study (Amer, et al 2002) 
 
The pesticide has been shown in animal testing and from use experience to 
affect the central nervous system, immune system, adrenal glands, liver, and 
 18
blood. Recent research also shows that malathion has a variety of harmful 
effects on birds. Malathion disrupted normal hormone activity, caused genetic 
damage, and reduced birds' food supply (George et al, 1995). It is considered 
moderate to very high in toxicity to fish and other water organisms. A study in  
(India) showed that a concentration of 50 ppb of malathion damaged red 
blood cells in the common fish Channa punctatus. (Sawhney and Johal, 2000) 
 
1.2.1.3. Fate in animals: 
Malathion is rapidly and effectively absorbed by practically all routes 
including the gastrointestinal tract, skin, mucous membranes, and lungs. 
malathion undergoes similar detoxification mechanisms to other 
organophosphates, but it can 
also be rendered nontoxic via another simple mechanism, splitting of either of 
the carboxy ester linkages. Animal studies indicate it is very rapidly 
eliminated though urine, feces and expired air with a reported half-life of 
approximately 8 hours in rats and approximately 2 days in cows (Gallo and 
Lawryk, 1991)                                                                                                                         
1.2.2. Carbamate pesticides- carbofuran: 
 
Carbofuran is a carbamate pesticide used to control a broad spectrum of 
insects on corn, rice, Alfa Alfa, grapes, and other foodstuffs. It is sprayed 
directly onto soil and plants just after emergence to control beetles, 
nematodes, and rootworm (U.S. 1EPA, 1995). It is available in liquid and 
granular formulations. 
 
Carbofuran was evaluated for an acceptable daily intake in 1978 and 1979 and 
a temporary ADI for man was estimated to be 0-0.003 mg/kg   body weight 
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(WHO and FAO 1980).  The available data reflected that carbofuran is a 
highly toxic carbamate ester whose metabolic profile has been well defined. 
 
 
1.2.2.1 Mode of action: 
 
Metabolism of carbofuran has been evaluated in rats, mice, insects, and 
plants. It appears that the main route consists of oxidation at the benzylic 
carbon to yield hydroxycarbofuran, which can then be hydrolyzed to 3-
hydroxycarbofuran phenol and 3-ketofuran-7-phenol. Another pathway of 
metabolism, which is more common in mammals than insects and plants, is to 
hydrolyze carbofuran directly to the carbofuran phenol (Metcalf, et al 1968, 
U.S. EPA, 1990).The anticholinesterase properties of the three major 
carbofuran metabolites were evaluated; particularly those with intact 
carbamyl moieties. The moieties, 3-hydroxycarbofuran, 3-ketocarbofuran, and 
3-hydroxy -N-hydroxy methylcarbofuran were found to have less 
anticholinesterase activity than carbofuran itself (Dorough, 1968; 1983). 
 
1.2.2.2Toxicity of Carbofuran: 
 
 Exposure to carbofuran causes a rapidly reversible direct cholinesterase 
inhibition. As with other carbamate compounds, carbofuran's cholinesterase- 
inhibiting effect is short-term and reversible (Kearney, and Kaufman 1975).  
The influence of carbofuran metabolism on acetylcholinesterase inhibition has 
been defined after low dose (50 µg/kg, i/v and oral) carbofuran exposures to 
male Sprague–Dawley Rats, showed that Red blood cell acetyl cholinesterase 
(RBC AchE) inhibition   was 83% at 2 min, 37% at 15 min for i/v and oral, 
respectively, 
with recovery by 3 hours and correlated with carbofuran plasma 
concentrations (Ferguson et al 1984). 
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The lethal effects of carbofuran are due largely to the chemical’s direct 
inhibition of acetyl cholinesterase. Ultimate cause of death is respiratory 
failure. Signs and symptoms of cholinesterase poisoning occur within minutes 
as carbofuran acts directly on the enzyme without metabolic activation 
(Tobin, 1970). 
Symptoms of carbofuran poisoning include: vomiting, abdominal cramps, 
sweating, diarrhea, excessive salivation, weakness, imbalance, blurring of 
vision, breathing difficulty, increased blood pressure, and incontinence. Death 
may result at high doses from respiratory system failure associated with 
carbofuran exposure (Baron, 1991).Clinical signs of anticholinesterase 
poisoning were seen in two treated groups of rats, consisting of tremors and 
teeth grinding (Ellman et al., 1961) 
Complete recovery from an acute poisoning by carbofuran, with no long-term 
health effects, is possible if exposure ceases and the victim has time to regain 
their normal level of cholinesterase and to recover from symptoms. The oral 
LD50 is 5 to 13 mg/kg in rats, 2 mg/kg in mice, and 19 mg/kg in dogs. The 
dermal LD50 is >1000 mg/kg in rabbits, (Baron, 1991). The LC50 (4-hour) 
for inhalation of carbofuran is 0.043 to 0.053 mg/L in guinea pigs; (Kidd and 
James, 1991).  
An evaluation was made on the possible differences in brain and erythrocyte 
cholinesterase activity in adult and juvenile rats of both sexes following acute 
exposure to carbofuran. Examination of the optimal sampling time for 
evaluating maximum erythrocyte cholinesterase depression showed that 
approximately 30 minute following acute administration was the optimal in 
both sexes in adults and juveniles. The data showed recovery was almost 
complete four hours following acute carbofuran treatment.  Complete 
recovery was noted at the 24-hour interval. It was quite evident that complete 
recovery of all enzyme depression was attained within one day (Case, 1980).  
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Chronic toxicity was recorded in carbofuran administered to rats caused a 
significant decrease in water consumption as well as in brain, serum and 
erythrocyte cholinesterase activities. Statistically significant increases in 
relation to the control were found in the serum enzyme activities (Dragica et 
al, 2008). 
 
1.2.2.3. Fate in animals:  
 
Administered carbofuran is rapidly excreted.  After 60 minutes, 6 % and 24 % 
of the dose from labeled carbofuran was detected in the exhaled breath and 
urine of mice, respectively. (Ahdaya et al, 1981) found that after eight hours 
of dermal administration, 72 percent of the dose was eliminated with 
approximately 2/3 in the feces and 1/3 in the urine of mice. The dose excreted 
by feces was approximately half of the administered dose. (Shah et al, 1981) 
 
1.3 Atropine:  
 Atropine is the best-known member of a group of drugs known as muscarinic 
antagonists, which are competitive antagonists of acetylcholine at muscarinic 
receptors. This naturally occurring tertiary amine was first isolated from the 
Atropa belladonna plant by (Weiner, 1985) although atropine earlier enjoyed 
widespread use in the treatment of peptic ulcer, today it is mostly used in 
resuscitation, anaesthesia, and ophthalmology, usually as the more soluble 
sulphate salt. By competitively blocking the action of acetylcholine at 
muscarinic receptors, atropine may act as a specific antidote.  
Atropine is usually prepared by extraction from the plants Atropa belladonna 
(deadly nightshade), D. stramonium (Jimson weed) or Duboisia myoporoides 
(McEvoy, 2002). This extracted atropine is a combination of D and L 
hyoscyamine, both these isomers may bind to muscarinic receptors (Berghem 
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et al, 1980), although the pharmacological activity is thought to be due almost 
entirely to L hyoscyamine (McEvoy, 2002). 
 Atropine sulphate occurs as odorless, very bitter, colorless crystals or white 
crystalline powder (Budavari, 1996, Parfitt, 1999). The alkaloid, atropine, is 
an organic ester which may be prepared synthetically by combining tropine 
and tropic acid (McEvoy 2002), but is usually obtained by extraction from 
some solanaceous plants (Parfitt, 1999). 
1.3.1 Mode of antidotal activity  
Atropine is a muscarinic cholinergic blocking agent. It competitively blocks 
parasympathetic, postganglionic nerve endings from the action of 
acetylcholine and other muscarinic agonists. Atropinic drugs have little effect 
at nicotinic receptor sites. Large doses of atropine produce only partial block 
of autonomic ganglia and have almost no effect at the neuromuscular 
junction. 
The peripheral antimuscarinic effects of atropine may not be the only 
antidotal property of the drug in organophosphate poisoning. Atropine may 
also be of value in treating acute dystonic reactions occasionally observed in 
acute organophosphate poisoning (Smith et al 1979; Joubert et al., 1984; 
Joubert and Joubert, 1988; Wedin, 1988). Patients with extrapyramidal signs 
have been noted to have abnormally low plasma and red blood cell 
cholinesterase activities, producing an excess of acetylcholine relative to 
dopamine (Wedin, 1988). However, there is little clinical evidence available 
on the possible anticonvulsive effects of atropine in man. 
It is a specific antidote for the treatment of poisoning with organophosphorus 
and carbamate insecticides the role of atropine in the treatment of 
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organophosphate poisoning is essentially unchallenged, though there is 
controversy concerning the dose of atropine necessary for optimal therapy in 
organophosphate poisoning. (Schoene et al, 1988) studied the efficacy of 
Atropine sulphate administered prior to dosing with paraoxon in mice. 
Atropine sulphate was administered 5, 20, 40 and 60 minutes before 
organophosphate administration and was found to reduce mortality 
significantly. 
In calves poisoned with intravenous Dichlorvos, atropine was shown to 
reverse the respiratory effects of the organophosphate (Likeux et al, 1986). 
Atropine may reverse changes in ventilation-perfusion inequalities resulting 
from uneven distribution of ventilation; caused by acetylcholine-mediated 
airway constriction (Slocombs and Robinson, 1987).Support for an 
anticonvulsant action of Atropine has been presented by (McDonough et al, 
1987) who found that Atropine pre-treatment prevented the development of 
convulsions and brain damage induced by soman or VX injected directly into 
the amygdala. 
1.3.2 Pharmacokinetics: 
 
 
Atropine is absorbed irregularly from the gastrointestinal tract, and more 
slowly than with parenteral dosing (Dollery, 1991). Intramuscular absorption 
of Atropine and Atropine sulphate depends on the method of injection, the 
site of injection (Friedl et al, 1989). Atropine and atropine sulphate reach 
peak plasma levels when injected intramuscularly in about 30 minutes 
(Berghem et al, 1980, Saarnivaara et al, 1985, Gervais et al, 1997). 
Atropine is metabolized in the liver by microsomal monooxygenases. HPLC 
separation of urine has identified 5 compounds: Atropine, Noratropine, 
Tropine, Atropine-N-oxide (equatorial isomer), and tropic acid. Thus, 
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Atropine is partly metabolized and partly excreted unchanged in the urine, the 
unchanged portion being approximately 50% (Van der Meer et al, 1983, 
1986). Intramuscular Atropine may slow small bowel transit time by 
approximately 38% (Hardison et al, 1979). Gastric emptying may also be 
delayed by atropine (Dollery, 1991). 
Atropine is the drug of choice for the treatment of the muscarinic symptoms 
and signs of poisoning with anticholinesterase agents (organophosphate or 
carbamate, particularly excessive salivation and lacrimation, 
bronchoconstriction and hypersecretion, pulmonary oedema and bradycardia. 
Animal studies have shown that Atropine alone significantly reduces 
mortality and counteracts features of toxicity due to most anticholinesterase 
insecticides. In several clinical case reports the administration of Atropine is 
clearly associated with a reduction of cholinergic features and a favorable 
outcome. (Andrew, 2000) 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1. Materials and experimental designs:  
 
Three experiments were run to determine the use of herbal antidote to the 
toxicity of some pesticides. In the first experiments the aqueous extract of 
D.stramonium seeds was used as pretreatment to toxicity induced by a 
carbamate (carbofuran), compared to reference drug Atropine sulphate. In the 
second experiment, the same extract was used as post treatment to toxicity 
induced by an organophosphorus (malathion).The third experiment was run to 
determine the safety of different levels of doses, of the aqueous seed extract 
of the plant.  
 
2.1.1 Pretreatment of carbofuran induced toxicity with D.stramonium 
aqueous extract: 
2.1.1.1 Animals, housing and management: 
 
Twenty five, male and female white (Albino) rats of weight 115-180 gm, 
were obtained from the Medicinal and Aromatic Plant Research Institute, 
National Centre for Research, Khartoum, Sudan on 23/1/2008. They were 
housed under standard environmental conditions, within the premises of the 
Medicinal and Aromatic Plant Research Institute. They were housed in cages 
in a room at controlled temperature (22± 2 ºc), relative humidity 60% with 
free access to water and formula rat feed (2.5 meal and 20% protein).Animals 
were apparently healthy and they were identified by tail color marks relevant 
to their groups. One week was allowed as preliminary adaptive period. 
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2.1.1.2 Administration and dose rates: 
 
At the end of the adaptation period, the animals were weight-distributed and 
allotted randomly to five groups, each of five rats. Group1 rats were treated 
orally with carbofuran 10 mg/kg dissolved in normal saline. Group 2 and 3 
were pretreated with D.stramonium seed aqueous extract (5 and 7.5 mg /kg 
body weight respectively dissolved in normal saline I/p, after 5 min each 
group was treated orally with carbofuran 10 mg/kg body weight. 
Group 4 rats were pretreated with Atropine sulphate 17 mg/kg body weight 
I/p. After 5 min they received carbofuran 10mg/kg. Group 5 served as 
unintoxicated untreated control. 
 
2.1.1.3 Parameters: 
 
Clinical signs were observed. Blood samples were harvested from the ocular 
vein. The blood samples were collected successively three hours post 
administration of carbofuran , six hours and twenty four hours. Blood samples 
were collected into dry clean bottles. Sera were analyzed for the concentration 
of cholinesterase and the activities of ALT, AST, and ALP and the 
concentrations of metabolic indicators, total protein, Albumin, globulin, urea 
and creatinine. The rats were scarified after twenty four hours, tissue 
specimens of liver, heart, and kidney. Spleen and brain were fixed in 10% 
buffered formalin and processed for histopathology. 
 
2.1.2 Treatment of malathion induced toxicity in rats with D.stramonium 
seed extract: 
2.1.2.1 Animals, housing and management: 
 
Twenty five, male and female white (Albino) rats of weight 115-180 gm, 
were obtained from the Medicinal and Aromatic Plant Research Institute, 
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National Centre for Research, Khartoum, Sudan on 23/1/2008. They were 
housed under standard environmental conditions, within the premises of the 
Medicinal and Aromatic Plant Research Institute. They were housed in cages 
in a room at controlled temperature (22± 2 ºc), relative humidity 60% with 
free access to water and formula rat feed (2.5 meal and 20% protein).Animals 
were apparently healthy and they were identified by tail color marks relevant 
to their groups. One week was allowed as preliminary adaptive period. 
 
2.1.2.2 Administration and dose rates: 
 
At the end of the adaptation period, the animals were weight- distributed and 
allotted randomly to five groups each of five rats. 
Group 1 received only malathion 500 mg/ kg/ body weight. Group 2 was 
exposed to Malathion 500 mg/kg /body weight and after half an hour treated 
with D. stramonium seed extract 5mg /kg/body weight, intraperitonially (I.P). 
The treatment dose was repeated after four hours. Group 3, received 
malathion 500 mg/ kg /body weight and after half an hour treated with D. 
stramonium seeds extracts at a dose of 7.5mg/kg /body weight I/P. The 
treatment dose was repeated after four hours. Group 4, were exposed to 
toxicity by malathion 500 mg /kg/ body weight orally and post treated with 
Atropine sulphate 17 mg/kg/body weight I/.P. The Atropine sulphate dose 
was repeated after four hours. Group 5 served as control group (unintoxicated, 
untreated). 
2.1.2. 3 Parameters: 
 
Clinical signs were observed. Blood samples were harvested from the ocular 
vein. The blood samples were collected three times. The first blood samples 
were collected after half an hour from the administration D. stramonium seed 
extract and Atropine sulphate . The second; after half an hour from the second 
treatment (by D. stramonium seed extract and atropine). The third blood 
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samples, after twenty four hours from the second treatment (by D. 
stramonium seed extract and atropine). Sera were analyzed for the 
concentration of cholinesterase and for the activities of Alanine amino 
transferase (ALT), Aspartate amino transferase(AST) and Alkaline 
Phosphatase (ALP). The concentrations of metabolic indicators, total protein, 
Albumin, globulin, urea and creatinine were also evaluated. The rats were 
scarified after twenty four hours; tissue specimens of liver, heart, kidney, 
spleen and brain were fixed in 10% buffered formalin and processed for 
histopathology. 
 
2.1.3 Toxicity of Datura Stramonium in white rats: 
 
2.1.3.1 Animals, housing and management: 
 
Twenty five, male and female white (Albino) rats of weight 115-180 gm, 
were obtained from the Medicinal and Aromatic Plant Research Institute, 
National Centre for Research, Khartoum, Sudan on 23/1/2008. They were 
housed under standard environmental conditions, within the premises of the 
Medicinal and Aromatic Plant Research Institute. They were housed in cages 
in a room at controlled temperature (22± 2 ºc), relative humidity 60% with 
free access to water and formula rat feed (2.5 meal and 20% protein).Animals 
were apparently healthy and they were identified by tail color marks relevant 
to their groups. One week was allowed as preliminary adaptive period 
2.1.3.2 Administration and dose rates: 
 
 
At the end of the adaptation period, the animals were weight- distributed and 
allotted randomly to four groups each of four rats. Group 1 received D. 
stramonium seed extract at a dose of 7.5 mg/kg intrapretonially, group2 
injected by the plant extract at a dose of 15 mg/kg intrapretonially, group 3, 
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received the plant extract at a dose of 30 mg/kg intrapretonially. Group 4, was 
untreated or the control group. 
 
2.1.13 parameters: 
 
Clinical signs were observed. The rats were sacrificed after twenty-four hours 
and blood samples were collected. Sera were analyzed for the activities of 
ALT, AST, and ALP and for the concentrations of metabolic indicators, total 
protein, albumin, globulin, urea and creatinine. Tissues specimens, of liver, 
heart, kidney, spleen and brain, were fixed in 10% buffered formalin and 
processed for histopathology. 
 
2.2. METHODS 
2.2.1 The extraction method (Aqueous extract) of the plant: 
 
D. stramonium plant collected in winter (in the middle of November  2007 ) 
from Shambat area near the river Nile bank. It possessed large numbers of 
ripened fruits. The plant is dried at room temperature. The seeds were 
gathered from the thorn apples -small black seed, (the seed weighed 
approximately 0.01g). 
The seeds weights were (78.35-gram).The coarse powder of the plant seeds 
were soaked in boiling distilled water and left for two hours at room 
temperature. The mixture was filtered. The filtrate was cooled over night at 
4ºC. The concentrated extract was freeze -  dried (Komolafe et al, 1988). The 
yields percentages were calculated and the residues were kept in the 
refrigerator until used. The extract weight was 12. 272 gm. 
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2.2.2 Histological methods: 
 
The specimens were collected immediately after slaughter and fixed in 10% 
buffered formal saline, embedded in paraffin wax, sectioned at 5 um and 
stained with heamotoxlin and eosin (H&E) using Mayere haemalum. 
 
2.2.3 Chemical methods: 
 
Blood samples obtained from the ocular vein of rats were used to prepare sera 
for the chemical methods, Venous blood samples were allowed to clot at 
room temperature for 30 minutes. Serum was separated by centrifugation at 
3000 R.P.M for 5 minutes and stored at -20 ºc until analyzed. 
Spectrophotometer (Merck Mega, Version 0.6 1995 E Merck, Dramstadt, 
Germany) was used to record serum activities of enzymes AST, ALT and 
ALP and serum metabolites, albumin, total protein, urea, creatinine and 
cholinesterase. 
 
2.2.3.1 Glutamyl oxaloacetic transeaminase(Aspartate amino transferase. 
L.Aspartate: 2-oxaglutarate amino- transferase. E C.6.1.1:G.O.T, A.S.T): 
 
Serum AST activity was measured by commercial kit (Randox Laboratories      
L td U.K) 
It is an enzymatic method that measures glutamic oxaloacetic transaminase in 
serum according to (Retiman and Frankel 1975) and (Schmidt and Schmidt, 
1963). 
 
2.2.3.1.1 Test principle: 
 
Aspartate aminotransferase, catalyses reversible transferase, of an amino 
group, aspartate to a- ketoglutrate and oxaloacetate. 
 
 31
2.2.3.1.2 Reaction: 
L-aspartate +a-oxoglutrate      GOT          L – Glutamate + Oxaloacetat 
 
The oxaloacetate produced is reduced to Malate by Malate Dehydrogenase 
(MDH) and NFDH. 
Oxalacetate +NDH + H        MDH     malate + NAD 
[ 
The rate of decrease in concentration of NADH is proportional to the catalytic 
concentration of AST present in the serum sample. 
 
2.2.3.1.3 Protocol: 
 
None – Heamolysed serum was added to buffered substrate mixture of L- 
aspartate and a-oxaloglutrate. The absorbance at a wave length of 365 nm was 
read at one minute intervals after mixing with the buffered substrate solution. 
The mean absorbance change per minute (A365/ minute) was used for 
calculation of enzymes activity as follows: 
IU=A365nm/miute ×2059. 
 
2.2.3.2 Orthophosphoric mono- ester phosphydrolase E.S.3.13.1; ALP. 
Alkaline Phosphatase: 
 
It optimized method according to recommendation of (Chemie 1972) 
 
 
2.2.3.2.1 Test principle: 
 
In alkaline medium serum alkaline phosphatase splits p- nitro phosphate, In 
the presence of Mg ions, into p- nitrophenyl and phosphate. At the PH of 
reaction, p- nitro phenyl was yellow. The optical density measured in 
spectrophotometer at wave length 405 nm. 
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2.2.3.2.2 Reaction: 
 
P-nitrophenyl phosphatase + H2O   ALP   inorganic Phosphate + p- 
nitrophenol 
 
2.2.3.2.3 Calculations: 
 
ALP is calculated as follows: 
U/I = 2760 × A405 nm/min 
(A = the mean of sample absorbance reading) 
 
2.2.3.3 Alanine amino transferase ALT (Glutamic Pyruvic transaminase, 
L_ aspartate,oxoglutamate: 
 
It is an enzymatic method, which measures glutamic pyruvic transaminase in 
serum according to Retimen and Frankel. (1975) and (Schmidt and Schmidt 
1963). 
 
2.2.3.3.1 Test principle: 
 
Alanine amino transferase are measured by monitering the concentration of 
pyruvic hydrazone formed with 2-4 dinitrophenylhydrazine 
 
2.2.3.3.2 Reaction: 
 
Oxoglutarate +L _ Alanine          GPT          L- glutrate + pyruvic 
2.2.3.3.3 Protocol: 
 
None – Heamolysed serum was added to buffered substrate mixture of L- 
Alanine and a-oxaloglutrate. The absorbance of samples was read against the 
blank after 5 minutes at wave length of 630 nm UV/VIS, Spectrophotometer. 
The ALT was measured in I.U/L. 
 IU=A630nm/miute ×2059. 
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2.2.3.4 Total protein: 
 
Total serum protein was measured by colorimetric method using a 
concentration kit (Randox laboratories, L td, U.K.) 
 
2.2.3.4.1 Test Principle: 
 
Colorimetric determination of total protein in serum is based on the Biruet 
reaction. The serum protein reacts with copper sulphate in the presence of 
sodium hydroxide. The Rochelle (K-Na- -tarterate) contained in the Biruet 
reagent is utilized to keep the formed cupric hydroxide in solution which 
gives the blue color. The intensity of the color produced is proportional to the 
amount of protein in the sample. The absorbencies of the sample, (A sample) 
and of the standard (A standard) were read against the reagent blank in the 
Spectrophotometer at a wave length of 545 nm. The total protein 
concentration (C) was calculated as follows: 
C (mg/dl) =          A sample      × concentration of the standard 
                            A standard 
 
2.2.3.5 Albumin: 
 
Serum albumin was measured by a colorimetric method using a commercial 
kit (Randox laboratories Ltd.,U.K 
 
2.2.3.5.1 Test principle: 
 
The measurement of serum albumin is based on its quantitative binding to the 
indicator 5, 5-di-BCP. 
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Serum was mixed with a buffered BCP reagent and the mixture was incubated 
for 2 minutes at room temperature. The absorbance of the sample (A sample) 
and of the standard (A standard) was measured against the reagent blank at 
wave length of 600 nm and albumin concentration (C) was calculated as 
follows: 
C (g/dl) =              A sample    × concentration of the standard 
                            A standard 
 
2.2.3.6 Globulin: 
 
Globulin concentration was detected by subtracting albumin concentration 
from total protein concentration as follows: 
C (total protein) – C (albumin) = C (globulin) 
 
 
2.2.3.7 Urea: 
 
Serum urea concentration was estimated by an enzymatic colorimetric method 
using a kit (Randox Laboratories L td, U.K.) 
 
2.2.3.7.1 Test principle: 
 
Ammonia and carbon dioxide are produced when urea is hydrolyzed by 
urease 
Urea +H2O   urease     Ammonium carbonate + CO2 
Ammonium ions react with phenol and hydro phenol and hydro chlorite to 
give a colored complex 
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2.2.3.7.2 Protocol: 
 
The serum was mixed with a buffered unease solution and the mixture was 
incubated 10 min at room temperature. The hydrochloride solution was added 
and mixed and the contents were incubated at room temperature for 15 min. 
The absorbency of the sample (A sample) and of the standard (A standard) 
were read against the blank at a wave length of 546 nm and the concentration 
(c) of the urea was calculated as follows: 
C (mg/dl) =          A sample      × concentration of the standard 
                          A standard 
 
2.2.3.8 Creatinine:   
 
 
  Serum creatinine concentration was measured by a colorimetric method 
using a commercial kit (Randox laboratories Ltd., UK) 
 
2.2.3.8.1 Test principal: 
 
Creatinine forms a colored complex with picric acid in an alkaline medium. 
The color intensity is proportional to the concentration of the reaction 
mixture. Serum was mixed with a mixture of pioric acid and Sodium 
hydroxide. Absorbance change/ minutes of the sample and the standard were 
recorded at wave length of 492 and the change in absorbance was used in 
calculations as follow: 
C (mg/dl) =      A sample      × concentration of the standard 
                      A standard 
 
 
2.2.3.9 Cholinesterase: 
 
Serum cholinesterase concentration was estimated by an enzymatic 
calorimetric method using a kit (Linear laboratories –Spain) 
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2.2.3.9.1 Principle: 
 
Cholinesterase (CHE) catalyzes the hydrolysis of butyrylthiocholine substrate 
forming butyrate and thiocholine. The latter reduces 5, 5´-mercaptobis-2-
nitrobenzoic acid (DMNB) to 5-mercapto-2-nitrobenzoate (5-MNBA), a 
colored compound. The reaction is monitored kinetically at 405 nm by the 
rate of information of the yellow color produced, proportional to the activity 
of (CHE) in the sample 1. 
Butyrylthiocholine + H2O            Butyrate + Thiocholine 
Tiocholine + DMNB                Oxidized thiocholine + 5-MNBA + H+ 
Dibucain inhibition can be estimated by performing concurrent assays in 
which dibucaine is present in the substrate mixture. Percent inhibition is 
evaluated by comparison of activity in the inhibited system with that in the 
uninhibited system. The resulting dibucaine number allows the classification 
and identity of the homozygous and heterozygous variants. 
 
2.2.3.9.2 Cholinesterase calculations: 
 
The difference in absorbance was used to calculate the concentration of 
Cholinesterase as follow: 
Total cholinesterase 
U/L = ∆A/30sec x 46222 (37ºC) 
U/L= ∆A405 nm/min 
U/L x 16.67 = nkat/L 
 
2.24 Statistical Method: 
 
 Data in serum enzyme and metabolites were subjected to one way analysis of 
variance ANOVA. Mean values were compared using un-paired student t- 
test. Data in serum enzyme and cholinesterase in variance treatments were 
drawn as histograms and compared (Snedecor and Cochram 1989)
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CHAPTER THREE 
RESULTS 
 
3.1 Pretreatment of toxicity induced by carbofuran with Datura 
stramonium aqueous extract: 
3.1.1 Clinical signs: 
 
Group1 (carbofuran 10mg/kg),this group treated by carbofuran alone as 
intoxicated control, signs of toxicity started after 5 minutes and include 
tremor, restlessness and inappitance, after 1hr one rat of the group died. The 
signs of toxicity continued for 3 hrs. In group 2 (Datura stramonium seeds 
extract 5 mg /kg body weight and carbofuran10 mg/kg), the signs of toxicity 
started after 5 minutes and include tremor, restlessness, and inappitance. No 
mortalities recoded and the signs of toxicity disappeared after 1 hour and 48 
min. In group 3 (Datura stramonium seed extract 7.5mg /kg body weight and 
carbofuran10 mg/kg ), in this group the signs of toxicity started after 6 
minutes this group showed the same clinical signs as in group 2 but less in 
severity. After 1 hour and 30 min. no signs were recorded. No mortalities 
were recorded. The rats in this group started to drink and eat normally after 2 
hours. Group 4 (Atropine sulphate 17 mg /kg body weight and carbofuran 10 
mg/ kg), In this group the clinical signs started after 11 minutes and they are 
the same in character to the previous ones but less in severity, after 1 hour and 
27 min. later 3 rats behave normally, the rest of the  two showed slight 
movement . 
 
3.1.2 Pathological changes: 
   In test group 1 (carbofuran 10 mg/kg), the changes in the organs are 
characterized by sever congestion and hemorrhages in the liver, kidney and
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Fig (4) Congestion, hemorrhage in liver and spleen in rat treated with 
carbofuran  
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heart (Fig 4).The brain of the same group showed congestion and 
hemorrhages. Where as in group 2 (D. stramonium seed extract 5 mg/ kg and 
carbofuran 10 mg/kg) the changes, in the liver, heart, and kidneys were, fatty 
changes, congestion and hemorrhages. The test groups (D. stramonium seed 
extract 7.5mg /kg body weight and carbofuran 10 mg/kg) and Atropine 
sulphate 17 mg//kg body weight and (carbofuran 10 mg/kg) had the same 
pathological changes fatty change in the liver, slight congestion the heart, 
brain and kidneys. 
 
 
3.1.3 Histological changes: 
 
Histopathological changes in livers in groups 1, 2, 3 and 4 were showen in fig 
5(A-D).The liver in-group 1(carbofuran 10 mg /kg) showed centrilobular 
necrosis and fatty changes. In-group 2 (D.stramonium seed extract 10 mg/kg 
and carbofuran 10 mg /kg there were scattered areas of necrosis of the 
hepatocytes and fatty changes. In group 3 (D.stramonium seed extract 7.5 
mg/kg and carbofuran 10 mg /kg) showed slight fatty changes and congestion. 
In group 4 (17 mg/kg and carbofuran 10 mg /kg) the liver showed slight fatty 
change. Other organs showed different pathological changes. In group1, the 
kidneys showed fatty changes of medudulary tubules. The brain showed 
severe meningitis with lymphocytic infiltration. In the heart, there was 
necrosis of the myocardium. In Group 2(D. stramonium seed extract 5mg /kg 
body weight and carbofuran 10 mg/kg) the heart showed mild necrosis. The 
same changes in the previous group were seen in the brain, kidney. Group 3 
(D. stramonium seed extract 7.5mg /kg body weight and carbofuran10 mg/kg) 
showed mild necrosis in the heart, there was mild infiltration in the brain. No 
histopathological changes in the spleen. In group 4 (Atropine sulphate 17 mg 
/kg body weight and carbofuran10 mg/kg), the heart, brain and kidneys had 
the same histopathological changes that seen in group 3. 
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A                                                                     B 
 
C                                                             D                         
  FIG (5) Sections of livers of rats treated with carbofuran , Atropine 
sulphate and D. stramonium seed extract 5 mg and 7.5 mg /kg body 
weight. 
A- Centrilobular necrosis and fatty changes in a liver of rat dosed with carbofuran 10 mg 
/kg (group 1). 
B- Scattered areas of necrosis of the hepatocytes and fatty changes in a liver of rat dosed 
with D.stramonium seed extract 10 mg/kg and carbofuran 10 mg /kg (group 2). 
C- Slight fatty changes and congestion in a liver of rat dosed with D.stramonium seed 
extract 7.5 mg/kg and crbofuran 10 mg /kg (group 3). 
D- Slight fatty change in a liver of rat dosed with Atropine sulphate 17 mg/kg and       
carbofuran 10 mg /kg (group 4). 
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Fig (6) Focal area of necrosis and fatty change in a kidney of rat dosed 
carbofuran 10 mg /kg 
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3.1.4 Changes in the serum constituents: 
Table (1) and Fig (7-10) shows the changes in serum constituents of rats 
pretreated with D.stramonium seed extract and intoxicated with carbofuran 
group. After three hours of administration of carbofuran the activities of 
cholinesterase is significantly reduced in-group 1(carbofuran) when compared 
to the control.  
The level of ALT increased significantly in-group 1(carbofuran) and group 
2(D. stramonium 5 mg/kg and carbofuran). The activities of ALP increased 
significantly in all the groups but group 1(carbofuran) had the highest level of 
this enzyme. The activities of AST, increased significantly in group 
1(carbofuran).The test groups 3 and 4 (D. stramonium 7.5 mg/kg and 
carbofuran and atropine group and carbofuran), show almost normal levels of 
these enzymes. Concentration of urea is increased in group1 (carbofuran), 
group 2(D. stramonium 5 mg/kg and carbofuran) and group 3 (Atropine 17 
mg/kg and carbofuran).No significant increase in creatinine level. Total 
protein, albumin and globulin showed no significant changes when compared 
to the control.      
After six hours after administration of carbofuran, levels of cholinesterase 
was increased in all the groups but it was significantly reduced when 
compared to the control group especially group 1(carbofuran). ALT and ALP 
began to decrease in all groups but the higher levels of these enzymes remain 
in group 1 (carbofuran) and group 2 (D. stramonium 5 mg/kg).AST began to 
decrease but group 1( carbofuran) still had a high level of this enzyme. Total 
protein is slightly decreased in group 1 (carbofuran) and group 2 
D.stramonium 5 mg/kg). There were no significant change in urea 
concentration .The level of creatinine was significantly increased in group 
1(carbofuran). 
After twenty –four hour after administration of carbofuran; the level of ALT 
and AST were slightly increased in group1 (carbofuran). ALP activity was
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Table (1) Analysis of variance and average (mean ±SE) values of serum constituents of rats pre-treated with Datura stramonium seed aqueous extracts and intoxicated with 
carbofuran:  
After three hours from the first treatment dose. 
groups ALT(i.u/l) AST(i.u/l) ALP(i.u/l) T,Protien(g/d)l Globulin(g/d)l Albumin(
g/d)l 
Urea (mg/dl) Creatinine(mg/dl) Cholinesterase(nkal)t 
F value** 12.7* 2.97* 5.98 2.18* 3.72 *. 1.05 0.73*  15.35*  0.54 
G 1  45.50±4 a  232.50±0.5 a 155.00±13.8 a 5.72±0.3 b 3.233±0.2 a 2.575±0.3 a 56.00±2.4 b 0.525±0.0 bc 389.7±104 b 
G 2 42.00±1.9a 175.00±8 b 142.50±10.2 bc  6.20±0.12 ab  3.03±0.2 a 3.10±0.0.7 a 45.2.60±3.1b 0.350±0.1 c 282.00±123.3 b 
G3 28.00±4.3c 153.60±2.2 b 112.50±8.5 bc 6.22±0.1 ab 2.92±0.0 a 2.70±0.1 a 30.00±0.5 a 0.60±0.1 ab 615.33±35.3 a 
G4 29.50 ±9bc 171.40 ±0.8b 121.20±10.1 b 6.02±0.1 ab 2.74±0.2  a 3.40±0.2 a 42.20±1.7 a 0.400±0.0 bc 654.33±74.1a 
G 5 26.66±6.5c 162.00 ±1.3b 89.00±5.4 c 6.47±0.2a 2.83±0.0a 3.63±0.0a 33.00±0.9 a 0.75±0.0 a 766.0±12 a 
 
After six hours 
 
groups ALT(i.u/l) AST(i.u/l) ALP(i.u/l) T,Protien(g/d)
l 
Globulin(g/dl) Albumin(g/d)
l 
Urea (mg/dl) Creatinine(mg/dl) Cholinesterase(nkal)t 
F value** 6.24*  7.82* 8.29* 3.89* 96* 0.22 8.94 4.99* 4.51* 
G 1 36.00 ±7.6a 195.50±1.4 a  113.25±8.7 a 5.57±0.3 c  2.97 ±0.2a 2.60±0.3 a 33.00±2.4 a  0.95 ±0a 492.67 ± 104b  
G 2 32.50±16.1b 178.50±2.5 b 126.33±2 ab 6.55±0.2 a 3.35±0.2a 3.20±0.1 a 30.66±2.5 a  0.47 ±0.1bc  600.33±123 a 
G3 28.60±9.8 c 165.80±3.2 b 84.40±8.5 c 5.84±0.2 bc 2.88±0 b 2.96±0.1 a 31.20±3.3a 0.44±0.1 c 695.33 ±35.4a 
G4 30.20±2 c 162.40±1.9 b 87.40 ±10.6 c 6.16±0.1 abc 2.88±0.3 b 3.0±0.1 a 34.0±2.3 a 0.62±0.0 b 700.33±74 a 
G 5 26.25±7.6 c 147.75 ±1.5b 85.00±6.8 c  6.37±0.2 ab 3.425±0.2 a 3.17±0.1 a 36.00±0.6 a 0.63 ±0b 711.00±12 a  
 
After twenty four hours 
 
groups ALT(i.u/l)  AST(i.u/l) ALP(i.u/l) T,Protien(g/d)
l 
Globulin(g/dl) Albumin(g/d)l Urea(mg/dl) Creatinine(mg/dl) Cholinesterase(nkal)t 
F value** 5.81 5.97* 24.67* 3.17* 3.10* 3.4* 5 1.55* 2.51 
G 1  30.25±2.4 a 176±2.2 a 109.0 ±6a 3.20±1b  2.65±0.1 b 1.55±0.2d  37.0±2a 0.2 ±0.1b  634.00±98 ab  
G 2  28.00± 2.7a b  149.6 ±1.6a  100.0±2.5 a 5.00±0.2 ab  3.15±0.1 a 3.15±0.1 ab  30.25 a  0.8±0.1 a  646.00±31 ab  
G3 26.20±14 b 171.0±3.9 a  85.0 ± 10.3 b 5.44±1.4 a 2.94±0.1 ab 2.74±1 c 32.0 ±3.1a 0.44 ±0.1ab 690.00±19.5 a 
G4 27.00±7.8 b 156.0±1.8a 90.2 ±0.2b 6.06 ±0.2a 3.24±0.1 a 2.92±0 bc 35.0±1.7 a 0.62±0 ab 700.0±59 a 
G 5 25.25±5.4 b 155.0 ±2.2a 90.0±4.5 b 6.62±0.2 a 3.15±0.2 a 3.4±0.7 a 35.0 ±0.0a 0.6±0.1 ab 710.00±33.5 a 
 
 G1 = (Carbofuran10mg/kg). 
 G2= (Datura seed extract 5mg /kg body weight and Carbofuran10 mg/kg: 
 G3= ( Datura seed extract 7.5mg /kg body weight and Carbofuran10 mg/kg 
 G4= ( Atropine 17 mg /kg body weight and Carbofuran10 mg/kg G5= (control). 
 Means with the same letter are not significantly different (.P> 0.05) 
*At (4, 20) degrees of freedom. ** 5% 
 
  
 
 
Fig. (7) Comparison between ALT levels in rats treated with carbofuran,          
Datura Stramonium seed extract and carbofuran and Atropine sulphate  
and carbofuran:  
 
G1 = (carbofuran 10mg/kg) 
G2= (D.Stramonium seed extract 5mg /kg body weight and carbofuran 10 mg/kg) 
G3= (D. Stramonium seed extract 7.5mg /kg body weight and carbofuran 10     mg/ kg) 
G4= (Atropine sulphate 17 mg /kg body weight and carbofuran 10 mg/ kg) 
G5= (control) 
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Fig (8) Comparison between ALP levels in And rats treated with carbofuran, 
Datura Stramonium seed extract and carbofuran and Atropine sulphate  
and carbofuran  
 
G1 = (carbofuran10mg/kg): 
G2= (D. stramonium seed extract 5mg /kg body weight and carbofuran 10 mg/kg) 
G3= (D. stramonium seed extract 7.5mg /kg body weight and carbofuran 10 mg/kg) 
G4= ( Atropine sulphate 17 mg /kg body weight and carbofuran 10 mg/kg ) 
G5= (control)   
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Fig (9) Comparison between AST levels in rats treated with carbofuran, 
Datura Stramonium seed extract and carbofuran and Atropine 
sulphate and carbofuran  
 
 
G1 = (Carbofuran10mg/kg) 
G2= (D. stramonium seed extract 5mg /kg body weight and carbofuran10 mg/kg) 
G3= (D. stramonium seed extract 7.5 mg /kg body weight and carbofuran10 mg/kg) 
G4= (Atropine  sulphate 17 mg /kg body weight and carbofuran10 mg/kg ) 
G5= (control)   
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Fig. (10) Comparison between cholinesterase levels in rats treated with 
carbofuran, Datura Stramonium seed extract and carbofuran and 
Atropine sulphate  and carbofuran  
 
G1 = (carbofuran10mg/kg): 
G2= (D. stramonium seed extract 5mg /kg body weight and carbofuran10 mg/kg) 
G3= (D. stramonium seed extract 7.5mg /kg body weight and carbofuran10 mg/kg) 
G4= ( Atropine sulphate 17 mg /kg body weight and carbofuran10 mg/kg ) 
G5= (control)   
 
 
 
 increased in group 1 (carbofuran) and group 2 D. stramonium 5 mg/kg and 
carbofuran).There were no significant changes in levels of urea, creatinine 
and cholinesterase in the rest of the groups. Total protein, albumin and 
globulin were significantly decreased in group1 (carbofuran) when compared 
to the control group. 
 
2.2 Treatment of malathion induced toxicity in rats with Datura 
stramonium seed extract: 
 
2. 2.1 Clinical signs: 
 
There were no obvious signs at the first half an hour of the experiment, 
except dullness and slow movement, for the four groups. After two and half 
hours, rats were provided with water and food. The treated groups 2, 3and 
4(groups treated by the plant extract and Atropine sulphate) began to take 
their water supply normally, but remained unappitante. The untreated group 
(malathion group showed no response to the presence of water. Three hours 
later, (after one hour from the second dose), all the groups provided with 
food. Only, the treated groups started to take their food. After twenty –four 
hours the color of feaces, of the untreated groups (malathion group) changed 
from black to grayish and some white.  
 
3.2 Pathological changes: 
 
 
There was significant difference in the color of the liver (pale color) between 
the treated groups (2,3and 4) and the untreated group. Group 1, the untreated 
group (malathion group) had pale liver with hemorrhages, the heart, spleen, 
brain, and kidneys were characterized by severe congestion and hemorrhages. 
In group2 (Treated by D. stramonium 5 mg /kg and malathion) showed one 
rat distended stomach, severe congestion in the heart, spleen with fatty 
 changes in the liver and scattered spots of necrosis in it's upper surface. In 
group 3 (treated by D. stramonium 7.5 mg/kg and malathion) showed one rat 
with distended stomach, fatty changes and congestion in the liver and kidney, 
no significant changes in the heart and brain. Group 4 (treated by Atropine 
sulphate and malathion) showed distended stomach with gases in three rats. 
The liver is slightly congested. The kidney showed fatty changes. No 
significant changes, in the heart and brain. 
 
3.3.3 Histological changes: 
 
Histopathological changes in livers in groups 1, 2, 3 and 4 were showen in 
(fig 11, A-D).In group1 the untreated group (malathion group), there were 
congestion, and generalized necrosis, in group 2 treated by D.stramonium 5 
mg/kg and malathion the histopathological changes  in the liver were 
congestion in the central vein, fatty change and centrilobular necrosis. The 
liver in-group 3 had fatty change and slight necrosis of the hepatocytes. In 
group 4 (treated by Atropine sulphate) the liver had slight congestion, fatty 
change and slight necrosis.Other organs also showed different pathological 
changes. In group1, in the heart, there was lymphocytic infiltration. The 
kidneys were severely congested; with lymphocytic infiltration, and severe 
necrosis of the cortical and meddullary tubules plus necrosis the glomeruli. 
The spleen showed severe congestion. The brain had severe leucocytic 
infiltration.In group 2 (treated by D.stramonium 5 mg/kg and malathion the 
heart, kidney and spleen was severely congested with lymphocytic 
infiltration. The brain had mild infiltration. In group3 (treated by 
D.stramonium 7.5 mg/kg), the heart was slightly congested. The kidneys 
changes were lymphocytic infiltration, shrinkage of glomeruli, haemosidrosis. 
The brain showed no significant histopathological changes 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (11) Sections of livers of rats treated with malathion , Atropine 
sulphate and Datura Stramonium seed extract 5mg and 7.5 mg 
/kg body weight seed extract 5mg and 7.5 mg /kg body weight. 
A- Congestion, and generalized necrosis, in a liver of rat dosed malathion 500 mg/ kg 
B- Congestion in the central vein, fatty change and centrilobular necrosis in a liver 
of rat dosed D. stramonium seed extract 5mg/kg and malathion 500 mg/ kg.                          
C- fatty change and slight necrosis of the hepatocytes in a liver of rat dosed D. 
stramonium seed extract 7.5mg/kg and malathion 500 mg/ kg. 
D- Slight congestion, fatty change and slight necrosis in a liver of rat dosed atropine  
A B 
C D 
 Group 4 (treated by Atropine. The heart showed no histological changes. The 
kidneys changes were lymphocytic infiltration, shrinkage of glomeruli, with  
fatty changes of the meddullary tubules. The spleens showed slight 
haemosidrosis. The brain showed no significant histopathological changes. 
 
3.4 Changes in the serum constituents: 
 
Table(2) and (fig 12-15) shows the changes in serum constituents of rats post-
treated by Datura  stramonium seed extract (two doses 5mg/kg b.wt/ rat and       
7.5 mg/kg b.wt/ rat) with regard to a reference drug –Atropine sulphate. After 
half an hour from the administration of the first treatment (by Datura 
stramonium seed extract and atropine) the activities of ALT increased 
significantly in group3 (malathion 500mg/kg/body weight and D. stramonium 
seeds extracts at a dose of 7.5mg/kg /body weight) , group 4 (malathion 
500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body weight) and 
group 1 (only malathion 500 mg /kg/ body weight).The ranges of AST and 
urea, increased significantly in all the groups but were highly increased, in 
group 1 (malathion 500mg /kg/ body weight).No significant increase in 
creatinine level. The level of cholinesterase,was significantly reduced in the 
four groups when compared to the control group .ALP was increased in group 
1( malathion 500 mg/kg /body weight), group 2 ( malathion 500mg/kg /body 
weight and D. stramonium seed extract 5mg /kg/body weight) and group 3( 
malathion 500 mg /kg /body weight and D. stramonium seed  extract 7.5mg 
/kg/body weight).Total protein, albumin and globulin showed no significant 
changes when compared to the control. 
  
After half an hour from the second treatment (by D. stramonium seed 
extract and Atropine sulphate) the activities of ALT, AST and ALP and urea 
increased significantly in group 1(malathion 500 mg/kg /body weight) and 
 slightly reduced in the other groups. These groups are not significantly 
different. No significant increase in creatinine level. The level of 
cholinesterase was significantly reduced in group1(malathion 500 mg /kg 
/bodyweight) and group2 (malathion 500mg/kg /body weight and D. 
stramonium seed extract 5mg /kg/body weight), when compared to the 
control group. Total protein, and globulin showed significant reduction in 
group4 (malathion 500mg/kg/body weight) when compared to the control). 
 
After twenty- four hours, the activities of ALT, AST, ALP urea and 
creatinine increased significantly in group1 (malathion 500mg/kg/body 
weight) while the level of cholinesterase is significantly reduced. Group4 
(malathion 500mg/kg/body weight and Atropin sulphate) and group3 
(malathion 500 mg /kg /body weight and D. stramonium seed extract 7.5mg 
/kg/body weight) showed normal levels of ALT, AST and ALP when 
compared to the control group, and the level of cholinesterase was 
significantly increased in these groups.  Group 2 showed a reduction in the 
level of cholinesterase and normal levels of ALT and ALP, while the level 
of AST was significantly increased when compared to the control. 
Total protein and albumin showed significant reduction, in group1 
(malathion500mg/kg/bodyweight) and group2(malathion 500 weight and  
D. stramonium seed extract 5mg /kg /body weight) when compared to the 
control Globulin was significantly reduced in group1 (malathion 500mg 
mg/kg /body).whereas in group3 (malathion 500 mg /kg /body weight and 
D. stramonium seed extract 7.5mg /kg/body weight) and group 4 malathion 
500mg /kg/bodyweight and Atropin sulphate) ,the level of total protein and 
albumin were not significantly reduced.
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Table 2 Analysis of variance and Average (mean ±SE) values of serum constituents of rats post-treated with Datura stramonium seed aqueous extracts and intoxicated with malathion:  
(TIME) After half an hour from the first treatment dose 
groups ALT(i.u/l) AST(i.u/l) ALP(i.u/l) T,Protien(g/dl) Globulin(g/dl) Albumin(g/dl) Urea (mg/dl) Creatinine(mg/dl) Cholinesterase(nkal)t 
F value 3.43* 1.57* 2.99* 1.08 1.07 3.25  3.61* 3.27 9.26* 
G1 51.0±  20.5 a 286.2±2.5.a 200.4±17.7 b 7.2 ±0.3a  3.2±0.4a 3.5 ±0.1ab 54.0±3.1a 0.620.1a 159.33 38.7 cd 
G 2  45.80±28.4ab 220.8±ab4.0b 197.2±27.3 b 7.3±0.3 a  3.7 ±a 3.3 ±0.1b  47.8 ±3.3bc 0.62a 126.67 d 
G 3 51.0011.6±a 227.0±ab4.7b 182.0±26.6 b  7.9±0.2 a 3.5±0.1a  3.2±0.2 b 42.8±3.0 bc 0.72±0.02 a 361.048.7 ab 
G4 52.00±19.1a 242±ab2.8b 118.6±8.9a 6.80±0.5a 2.7 ±0.5a 3.6±0.2ab 50.6±3.7 bc 0.880.1 a 363.6737.2 ab 
G5  33.33 bc 178.33ab 110.0a  7.6 a 4.1± a 4.13a 38.67c 0.83 a 477.5 a 
)TIME (  After half an hour from the second treatment dose 
groups  ALT(i.u/l) AST(i.u/l) ALP(i.u/l) T,Protien(g/dl) Globulin(g/dl) Albumin(g/dl) Urea(mg/dl) Creatinine Cholinesterase(nkal)t 
F value 5.87 5.72  5.07 3.23 4.31  3.19  1.187 1.95 16.08 
G1  82.4 ±15.2a 293.80 ±15.1a  196.2±5.3a 5.8±0.2 b 2.4±0.3b 3.16±0.3 b 48.80 ± 5.7a 0.8±0.1 ab  277.00 ±28.7c  
G2  42.6±31.2 b  230.0 ±5.2 b 137.60 ±18.1b 6.9 ± 0.1ab 3.6±0.3a 3.2 ±0.1ab 47.80±3.3a 0.6±0.1 b 291.67±30.4 c 
G3 47.8±10.2b  219.00±3.4  b  115.80±20.5b  6.84±0.3 ab 3.2±0.2a  3.52±0.3ab 40. 0± 8.9a 0.9± 0.9a 351.67±40. 2 ab 
G4  50.2±b9.5b 190.8 ±4.3b 117.00±10.5 b 7.00±0.6a 3.78 ±0.1a 3.1 ±b 50.25 ±a 0.72±0.3 ab 394.67 ±22.1ab 
G5 29.75±4.7b 173.75 ±1.7 b  111.25±7.7 b 7.62±0.2 a 3.6±0.3a 4.05±0.1 a 38.25 ±0.6a 0.75±0 ab 486.00±103.5a 
 
(TIME) after twenty-four hours  
groups ALT(i.u/l) AST(i.u/l) ALP(i.u/l) T,Protien(g/dl) Globulin(g/dl) Albumin(g/dl) Urea (mg/dl) Creatinine Cholinesterase(nkal
)t 
F value  4.69 8.14 17.23 5.46 4.89 6.63 1.58 3.72 8.20 
G1 91.40 ±28a 317.60 ±68a 210.60 ±10.9a 4.8 ±0.7c 1.6 ±0.6b 2.72±0 b 62.60±5.8b 0.94±0.2 a 216.67±10.3 b  
G2  45.60±23.7 b  257.4±5.5 b 110.20 ±15.2b 5.80 ±0.4bc  2.8±0 a 2384±0.2b 48.20±5.6 a 0.5±0.6 c 253.00±36.5 b  
G3 38.00 ±2.07 b 218.4±5.6bc 105.60 ±13.2b 7.24 ±0.6ab 3.5±0.2 a 3.68±0.4a 40.20±6.3a 0.8 ±0.1ab 353.00 ±72.6a 
G4 35.00± 8.3b 188.80± 1.2c 106.60±5.2 b 6.18 ±0.2abc 2.84±0.4 a 3.34 ±0.1ab 40.40± 3.8 a 0.58±0.1 bc 370.33±57a 
G5 29.75±3.8b 173.75±1.7 c 105.60 ±7.2b 7.650 ±0.2a 3.85±0.1a 3.97±0a 37.75±0.6 a 0.8±0.1ab 485.67±45 a 
 
G1=only Malathion 500mg/kg/body weight. 
G2=Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body weight 
G3= Malathion 500mg/kg /body weight and Datura seed extract 7.5mg /kg/body weight. 
G4 =.malthion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body weight. 
G5=Control 
 
Means with the same letter are not significantly different (.P> 0.05) 
*At (4, 20) degrees of freedom. ** 5% 
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Fig. (12). Comparison between ALT levels in rats treated with malathion, 
Datura stramonium seed extract and malathion and Atropine and 
malathion  
 
G1= Only Malathion 500mg/kg/body weight  
G3= Malathion 500mg/kg /body weight and Datura seeds extracts at a dose of 
7.5mg/kg /body weight 
G2= Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body 
weight 
G4= Malathion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body 
weight 
G5= Control   
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Fig. (13). Comparison between AST levels in rats treated with 
malathion, Datura stramonium seed extract and malathion 
and Atropine sulphate and malathion  
 
G1= Only Malathion 500mg/kg/body weight   
G3= Malathion 500mg/kg /body weight and Datura seeds extracts at a dose of 
7.5mg/kg/body weight   
G2= Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body 
weight    
G4= Malathion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body 
weight 
G5= Control  
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Fig. (14) Comparison between ALP levels in rats treated with 
malathion, Datura stramonium seed extract and malathion 
and Atropine sulphate  and malathion  
G1=only Malathion 500mg/kg/body weight.    
G3= Malathion 500mg/kg /body weight and Datura seeds extracts at a dose of        
7.5mg/kg /body weight 
G2= Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body   
weight 
G4= Malathion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body 
weight 
G5=Control    
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Fig (15) Comparison between cholinesterase levels in rats treated with    
malathion, Datura stramonium seed extract and malathion and 
Atropine sulphate and malathion  
 
 
G1= Only malathion 500mg/kg/body weight  
G2= Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body 
weight 
G3= Malathion 500mg/kg /body weight and Datura seeds extracts at a dose of 
7.5mg/kg /body weight 
G4= Malathion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body 
weight 
G5= Control   
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3 Toxicity of Datura stramonium in white rats:   
3.3.1 Clinical signs: 
 
There were no apparent signs of toxicity in the three treated groups. 
 
33.2 Pathological changes: 
 
At postmortem no pathological lesion were seen in group 1 (D. stramonium          
7.5 mg/ kg) while in group 2 and 3(D. stramonium15 and 30 mg/ kg) 
showed severe congestion and hemorrhages in the liver, heart, and kidneys. 
 
3.2.3 Histological changes: 
 
No histopathological changes in the internal organs were recorded in 
group1                     (D. stramonium 7.5 mg/kg). Group2 and 3(D. 
stramonium 15 and 30 mg/kg), the heart showed congestion and necrosis of 
the myocardium. The liver had severe necrosis, congestion and infiltration. 
The kidney showed dilation of the tubules with lymphocyte infiltration. 
The spleen had haemosidrosis. In the brain there was lymphocytic 
infiltration. The two groups had the same histopathological changes with 
lesser severity in group2 (D. stramonium 15 mg/kg). (Fig. 16) 
 
3.2.4 Changes in the serum constituents: 
 
Table (3) shows the changes in serum constituents of rats treated with D. 
stramonium seed extract at three level doses. The activities of ALT, AST 
and ALP increased significantly in group2 (D. stramonium seed extract 
15mg /kg body weigh) and group 3 (D. stramonium seed extract 30 mg/kg 
body weight). Creatinine level was significantly increased in group 3 (D. 
stramonium seed extract 30 mg/kg body weight) when compared to the 
control group. 
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Fig.(16) Sections of livers of rats treated with Datura stramonium seeds 
extract. 
 
A- Necrosis, congestion of the central vein in a liver of rat dosed 
D.strramonium seed extract 15 mg/kg 
B- Severe necrosis, congestion of the central vein in a liver of rat dosed 
D.strramonium seed extract 30mg/kg 
 
 
 
 
 
  
A 
  
B 
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Table 3: Analysis of variance and average (mean ±SE) values of serum 
constituents of rats treated by Datura stramonium aqueous extracts 
 
GROUPS ALT(i.u/l) AST(i.u/l) ALP(i.u/l) Albumin (g/dl) Urea(mg/dl) Creatinine(mg/dl) 
F value** 21.03* 3.31* 2.26* 0.39 1.03 5.67* 
Group 1 19.25±4b 86.00±1.5 b 39.75±0.5a 1.70±0.7a 2.50a 0.15±b 
Group2 20.75±7.8 b 131.00±3.0ab 45.00±1.4b 1.70±0.3a 26.25± 0a 0.22±1b 
Group3 96.67±22 a 156.67±1 a 48.25±3.7b 2.06±0.3a 29.00±0a 0.36± 4.6a 
Group4 14.50±29.6 b 72.00±17.6 b 40.50±1.2a 1.10±0.4a 22.0±0.3a 0.20±0.5b 
 
G1=D.strramonium seed extract 7.5mg /kg body weight. 
G2= D.strramonium seed extract 15mg /kg body weight. 
G3= D.strramonium seed extract 30 mg/kg body weight. 
G4= control 
Means with the same letter are not significantly different (.P> 0.05) 
*At (4, 12) degrees of freedom. ** 5% 
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CHAPTER FOUR 
DISCUSSION 
 
The present study has been an attempt to determine the efficacy of D. 
stramonium seed extract as an antidote to certain toxicities of insecticides 
(organnophosphurus and carbamate). 
 
In this study the use of D. stramonium seed extract as protective agent in 
carbamate poisoning revealed that, the levels of ALT, AST and ALP at the 
first three hours in the groups treated by the plant extract (7.5 mg) and that 
treated by the drug Atropine, were likely similar to the control group, while 
the levels of these enzymes were significantly high, in the untreated group. 
Case (1980) made an evaluation on the possible differences in brain and 
erythrocyte cholinesterase activity in adult and juvenile rats of both sexes 
following acute exposure to carbofuran. Examination of the optimal 
sampling time for evaluating maximum erythrocyte cholinesterase 
depression showed that approximately 30 minute following acute 
administration was the optimal in both sexes in adults and juveniles. The 
data showed recovery was almost complete four hours following acute 
carbofuran treatment.  Complete recovery was noted at the 24-hours 
interval. It was quite evident that complete recovery of all enzyme 
depression was attained within one day.  
 While this study showed that the treatment with the extract and Atropine 
sulphate decreased the level of the enzyme cholinesterase compared to 
untreated group, before the four hours mentioned in the previous mentioned 
study. There were almost, complete enzyme recovery, in three hours time. 
The histopathological changes in the liver, heart brain and spleen were the 
same changes that seen in the two treated groups by the plant extracts (7.5 
mg/kg) and 
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that treated by the drug (Atropine sulphate). These results indicate that the 
dose of D. stramonium seed extract 7.5 mg/kg body weight, have almost 
the same effects of Atropine sulphate in treatment of toxicity. 
 
The histopathological changes seen in the treated groups (by the plant 
extracts (5 mg/kg) and the untreated group were almost the same. After 
twenty –four hours the levels enzymes ALT, AST and ALP and the 
concentration of urea and creatinine were similar to the control group with 
slight increase in level of AST in the untreated group. The concentration of 
total protein, albumin and globulin were significantly decreased in group1 
(carbofuran) when compared to the control group.  Almost complete 
recovery of most of the enzymes was retained in twenty-four hours 
compared to three hours time recovery of the other two groups (Atropine 
and D. stramonium 7.5 mg/kg). These preliminary pretreatment suggest the 
possibility of using the extract as a post treatment antidote for carbamate 
poisonings. 
 
The study for evaluating the use of D. stramonium seed extract as a post 
treatment in malathion poisoning had showed significant increase in ALT 
during the first half an hour which indicated tissue damage. This also 
recorded in study by (Murphy, 1966) that after single intraperitoneal or oral 
doses of malathion, trichlorofon or dioxathion in rats, an increase in the 
activities of  liver tyrosine transaminase and alkaline phosphatase, as well 
as a decrease in the level of adrenal ascorbic acid were found. Further 
results of this experiment support the hypothesis that acute poisoning may 
produce metabolic alterations which are mediated through the pituitary-
adrenal system. 
 
After half an hour from the second dose, the levels of AST, ALT and ALP 
in group 2, 3 and 4(D. stramonium 5mg/kg, D. stramonium 7.5 mg/kg and 
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Atropine sulphate)  were reduced and significantly different from the 
control group. After twenty four hours the levels of these enzymes in all the 
groups, reduced almost to the normal except for the malathion group. 
Group 2 (D. stramonium 5mg) had slightly higher enzymes levels than 
group 3 and 4(D. stramonium 7.5 mg/kg and Atropine).These results 
together with histopathological changes which recorded similar 
pathological lesions of group 3and 4(D. stramonium 7.5 mg/kg and 
Atropine sulfate) Indicate the effective action of the treatment. 
 
The levels of total protein, globulin and albumin; which showed high 
reduction in malathion group and recorded that the levels of the metabolic 
indicators had lesser values when compared to group 3 and 4 (D. 
stramonium 7.5 mg/kg and Atropine), can pointed out another evidence of 
the extract protective effect.  
 
There was apparent reduction in cholinesterase activity in all the groups 
during the first half an hour after the first dose and this was recorded by 
(Frawley et al., 1957), who study the simultaneous administration of 
malathion and ethyl pnitrophenyl thionobenzenephosphate (EPN) results in 
a potentiation of the cholinesterase inhibitory effect of malathion in the 
mouse, rat and dog. The level of this enzyme began to increase after twenty 
–four hour especially in group 3 and 4 (D. stramonium 7.5 mg/kg and 
Atropine) which means that the body began to eliminate malathion from 
its tissues. 
 
[  The organophosphate induce reductions in dynamic lung compliance, 
arterial oxygen tension, increase in total pulmonary resistance, work of 
breathing and alveolar arterial oxygen gradient, were reversed by Atropine 
sulphate. Atropine may therefore, reverse changes in ventilation perfusion 
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inequalities resulting from uneven distribution of ventilation, caused by 
acetylcholine-mediated airway constriction (Slocombs and Robinson, 
1987). This resemble other studies in antidotal activities in calves poisoned 
with intravenous dichlorvos, Atropine was shown to reverse the respiratory 
effects of the organophosphate (Likeux et al., 1986). Atropine increases 
the survival of rats by reversing the action of acetylcholine at muscrinic 
receptors and minimizes air way constriction. While the extract of D. 
stramonium, has a long duration of effect. (Clancy et al., 2001) 
The usual duration of anticholinergic effect following exposure to the D. 
stramonium extract is 12–48 hours. (Levy 1977, Chang et al., 1999 and 
Clancy et al., 2001)This long duration of clinical effect has potential 
advantage in the treatment of OP toxicity since the effect of most OP will be 
long. Patients treated with this extract may not require additional doses of 
antidote. D. stramonium cross the blood–brain barrier, and has central 
anticholinergic effects and antagonizes the peripheral muscarinic receptor. 
(Clancy et al 2001) The high concentrations of these anticholinergic 
alkaloids in the D. stramonium seeds make an extract of this plant a 
potentially useful agent for the treatment of organophosphorus toxicity.  
 
In our study to determine the safety of the mentioned dose of D. 
stramonium seed extract 7.5 mg/kg body, and to evaluate the possibility of 
increasing this dose, the study showed that the level of ALT, AST and ALP 
were significantly high in the other doses 15, 30 mg/kg body weight. 
 
As  the measurements of ALT, AST and ALP enzymes renders a reliable 
assessment of liver damage (Gupita et al 2004); our study showed that 
increased level of this enzymes, in 15mg and 30 mg group indicates 
hepatonephropathy changes. This result was correlated with the result 
obtained with the toxicity of some plants namely Aristolochia brachteta 
toxicity in goats (Barakat 1978; Barakat et al., 1978; Eldirdiri et a.,l 1987 ) 
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and resembles those lesions detected in goat intoxicated with Capparis 
tementosa (Siham et al., 1993), also the postmortem findings in the  
toxicity of datura stramonium in sheep and goats (El Dirdiri et al., 1981). 
The  normal levels of the same enzymes revealed no toxicological evidence 
of the dose used (7.5 mg of Datura stramonium seeds extract) together with 
the result of histopathology indicated the safety effect of this dose. At the 
same time the possibility of increasing the dose may be toxic to the animal. 
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Conclusion: 
1.  The protective action D. stramonium seed extract against the two 
insecticides tested was dose dependant. 
2. Treatment with D. stramonium seed extract has a significant protective 
action in a rat model of organophosphorus and carbamate poisoning. 
3. The dose of D. stramonium seed extract 7.5mg/ kg body weight/ rat is 
safe and the possibility of increasing the dose could be toxic to animals. 
 
 
 
Suggestions for future work: 
 
1. Evaluation of the plant extract as antidotal agent in other species where 
the symptoms of toxicity is apparent. 
2. Estimate the benefit of the dose repetition according to specific time 
interval. 
3. Evaluation of any toxicity produced by other extracts of the plant. 
4. Evaluation of D.stramonium against other commonly used 
organophosphorus and carbamate compounds. 
5. Future studies should evaluate the effect of other routes of administration 
of the extract such as via the intragastric, oral , mucosal or sublingual 
route. 
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